<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS206357</article-id><article-id pub-id-type="doi">10.1101/2025.06.06.658024</article-id><article-id pub-id-type="archive">PPR1032840</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Competing 5’ splice sites of SRC1/HEH1 are marked for alternative splicing by U5 and U6 snRNAs during the B to Bact transition of the spliceosome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Banyal</surname><given-names>Ankita Katoch</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Choudhuri</surname><given-names>Poulami</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pillai</surname><given-names>Balashankar R</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">2</xref></contrib><contrib contrib-type="author"><name><surname>Varikkapulakkal</surname><given-names>Amjadudheen</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mishra</surname><given-names>Shravan Kumar</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Biological Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01vztzd79</institution-id><institution>Indian Institute of Science Education and Research (IISER)</institution></institution-wrap><city>Mohali</city>, <country country="IN">India</country></aff><author-notes><corresp id="CR1"><label>*</label>To whom correspondence should be addressed. <email>skmishra@iisermohali.ac.in</email></corresp><fn id="FN1" fn-type="present-address"><label>2</label><p id="P1">Present Address: Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Dr. Bohr-Gasse 3,1030 Vienna, Austria</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>12</day><month>06</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>07</day><month>06</month><year>2025</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P2">Alternative splicing of precursor-messenger RNA (pre-mRNA) bearing introns with competing and overlapping 5’ splice sites (5’SS) produces more mRNAs. We investigated the mechanism of this form of alternative splicing by monitoring RNA and protein products of the yeast <italic>SRC1/HEH1</italic> gene. Its alternative splicing requires a sixteen-nucleotide pre-mRNA segment spanning the two 5’SS. The nucleotides are decoded by U5 and U6 small nuclear RNAs (snRNA), further supported by proteins of the spliceosomal B and Bact complexes. Specific variants of the pre-mRNA segment with recalibrated binding to U5 and U6 snRNAs allowed alternative splicing independently of the trans-acting proteins. Conversely, snRNA variants specified for modified 5’SS selection suppressed the splicing defects in the B complex mutants. Further data suggest that alternative splicing from <italic>HEH1</italic>-type introns containing overlapping and competing 5’SS relies on pre-mRNA-snRNA interactions during B to Bact transitions of the spliceosome, supported by proteins that stabilize low-fidelity, high-efficiency conformations.</p></abstract><kwd-group><kwd>Alternative 5’ splice site</kwd><kwd>Prp8</kwd><kwd>RES complex</kwd><kwd>Ecm2</kwd><kwd>U5 snRNA</kwd><kwd>U6 snRNA</kwd><kwd>B complex</kwd><kwd>Bact complex</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3">Spliceosomes are large and dynamic ribonucleoprotein (RNP) complexes essential for constitutive and alternative splicing of precursor messenger RNAs (pre-mRNA). Each splicing cycle requires intricate rearrangements of five RNPs made of small nuclear RNAs (snRNAs) and their associated proteins (snRNPs). The snRNPs recognise and act through splicing signals of pre-mRNAs, including the donor 5’ splice site (5’SS) GU, the acceptor 3’ splice site (3’SS) AG, and the branch point (BP) adenosine. Two steps of the transesterification reactions, catalysed by divalent metal ions and U6 snRNA, remove introns and join exons to form functional mRNA<sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref></sup>. Alternative recognition of these signals can produce more mRNAs from a gene, thereby amplifying protein diversity from the limited gene pools in the organism<sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref></sup>.</p><p id="P4">Different classes of alternative splicing exist in eukaryotes. Key among them occurs through the selection of the alternative 5’SS<sup><xref ref-type="bibr" rid="R5">5</xref></sup> and 3’SS<sup><xref ref-type="bibr" rid="R4">4</xref></sup>. Splicing through competing 5’SS is a prevalent mode of alternative splicing. A majority of pre-mRNAs in the budding yeast <italic>Saccharomyces cerevisiae</italic> use the highly conserved GUAUGU hexanucleotide donors<sup><xref ref-type="bibr" rid="R6">6</xref></sup>, but 5’SS sequences are highly variable in intron-rich eukaryotes, where alternative 5’SS selection is widespread<sup><xref ref-type="bibr" rid="R7">7</xref></sup>. Two major classes of 5’SS (NN/GURAG and AG/GUNNN), distinguished by the presence of ‘G’ at -1 and +5 positions, have been reported<sup><xref ref-type="bibr" rid="R8">8</xref></sup>. Alternative 5’SS are often found 4 nucleotides across the dominant 5’SS, and such occurrences in humans are estimated to be in the thousands<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref></sup>. The canonical GU dinucleotide deviates to GC in 0.87% of the 5’SS<sup><xref ref-type="bibr" rid="R11">11</xref>.</sup> The <italic>HEH1/SRC1</italic> gene <italic>S. cerevisiae</italic> possesses a similar alternative 5’SS.</p><p id="P5">Alternative splicing of <italic>HEH1</italic> pre-mRNA occurs through two non-canonical 5’SS hexanucleotides, /GCAAGU and /GUGAGU, arranged as a partially overlapping sequence: /GCAA/GUGAGU (bent lines indicate cleavage sites)<sup><xref ref-type="bibr" rid="R12">12</xref></sup>. The downstream 5’SS, /GUGAGU, is the dominant one and generates mRNA-encoding the longer Heh1L full-length protein, whereas splicing from the weaker upstream 5’SS /GCAAGU is tightly regulated and produces mRNA-encoding the shorter Heh1S protein (by gaining the tetranucleotide GCAA, <italic>HEH1S</italic> mRNA’s frame shifts at the exon-exon junction and acquires an in-frame stop codon in exon-2). The two proteins share a common N-terminus but differ in their C-termini, resulting in distinct topologies within the inner nuclear membrane. Heh1L is a double-pass membrane protein, with both its termini in the nucleoplasm, while Heh1S is a single-pass membrane protein with only the N terminus in the nucleoplasm<sup><xref ref-type="bibr" rid="R13">13</xref></sup>. Heh1 protein controls the expression of sub-telomeric genes<sup><xref ref-type="bibr" rid="R13">13</xref></sup>, anchors rDNA repeats<sup><xref ref-type="bibr" rid="R14">14</xref></sup> and telomeric chromatin towards the nuclear periphery<sup><xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R15">15</xref></sup> and helps in chromatin silencing. Heh1S protein regulates Heh1L. The latter, if present alone, leads to the formation of aberrant nuclear pore complexes NPC<sup><xref ref-type="bibr" rid="R16">16</xref></sup>.</p><p id="P6">5’SS selection relies on early pre-mRNA recognition by trans-acting U1 snRNA and associated proteins<sup><xref ref-type="bibr" rid="R17">17</xref>–<xref ref-type="bibr" rid="R19">19</xref></sup>. The role of specific RBPs (RNA-binding proteins), SR (serine/arginine-rich) proteins, and hnRNPs (heterogeneous nuclear ribonucleoproteins) has also been reported in the context of 5’SS selection<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R20">20</xref>–<xref ref-type="bibr" rid="R25">25</xref></sup>. These proteins act as splicing enhancers and silencers, and regulate spliceosome assembly on pre-mRNA targets in association with U1 snRNP. Later spliceosomal assemblies in 5’SS selection in humans have been recently reported<sup><xref ref-type="bibr" rid="R26">26</xref></sup>.</p><p id="P7">The <italic>HEH1/SRC1</italic> gene is an interesting tool for studying RNA and protein factors involved in alternative splicing through competing and overlapping 5’SS. Its alternative splicing is controlled by the ubiquitin-like protein Hub1 (UBL5 in humans) through non-covalent associations with the U1 and U2 snRNPs, bridging RNA helicase Prp5<sup><xref ref-type="bibr" rid="R27">27</xref></sup> and the U4/U6.U5 tri-snRNP protein Snu66<sup><xref ref-type="bibr" rid="R28">28</xref></sup>. Thus, Hub1 acts early in spliceosome assembly by activating the RNA helicase, as well as later with the tri-snRNP component<sup><xref ref-type="bibr" rid="R29">29</xref></sup>. The latter activity suggests a possible role of the spliceosome core in <italic>HEH1</italic> 5’SS selection. Interestingly, we find that <italic>HEH1</italic> alternative splicing required optimal pairing of U5 and U6 snRNAs across a sixteen-nucleotide segment at the exon1-intron boundary of the pre-mRNA encompassing the competing and overlapping 5’SS. The 5’SS selection by the U5 and U6 snRNAs was supported by specific proteins of the spliceosome core, including Prp8.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Identification of trans-acting factors for <italic>HEH1</italic> alternative splicing</title><p id="P8">In the competing and overlapping 5’SS: /GCAA/GUGAGU of <italic>SRC1/HEH1</italic> pre-mRNA, the usage of the weaker upstream 5’SS: /GCAAGU was reported to require the ubiquitin-like protein Hub1 and its non-covalent binding partner Snu66 in the tri-snRNP complex. The dominant 5’SS: /GUGAGU was selected independently of Hub1<sup><xref ref-type="bibr" rid="R28">28</xref></sup>. However, the mechanism of 5’SS selection is not understood. We reasoned that by finding additional factors of this process, alternative 5’SS selecting spliceosomal complexes may be identified. Thus, we searched for <italic>HEH1</italic> alternative splicing factors in <italic>Saccharomyces cerevisiae</italic> through the following approaches.</p><p id="P9"><italic>(i) HEH1−LACZ alternative splicing reporters</italic>: Along the line of <italic>RP51-LACZ</italic> splicing reporter<sup><xref ref-type="bibr" rid="R30">30</xref></sup> we prepared <italic>HEH1</italic> alternative splicing reporters <italic>HEH1S</italic>−<italic>LACZ</italic> and <italic>HEH1L</italic>−<italic>LACZ</italic> (<xref ref-type="supplementary-material" rid="SD1">Figure S1a</xref>) by placing <italic>HEH1</italic> gene segment containing parts of both exons flanking the intron upstream of the β galactosidase-encoding <italic>LACZ</italic> gene such that yeast cells would produce in-frame translatable reporter only after precise 5’SS selections and excision of the intron. Reporter activities were monitored in cells growing on solid and liquid media. Besides the Hub1 mutant, reduced activity from the alternative 5’SS was also observed in the deletion mutants of the RES<sup><xref ref-type="bibr" rid="R31">31</xref></sup> (Retention and Splicing complex) complex subunits Snu17, Bud13, Pml1, and Urn1. The deletion of the NTC (Nineteen complex) factor Ecm2<sup><xref ref-type="bibr" rid="R32">32</xref></sup> strain also showed similar defects in 5’SS selection (<xref ref-type="supplementary-material" rid="SD1">Figure S1b and c</xref>). By contrast, the usage of the dominant 5’SS remained unaltered in these mutants, suggesting a role of these proteins in the selection of the weaker 5’SS.</p><p id="P10"><italic>(ii) Heh1 protein isoforms</italic>: The relative abundance of the two Heh1 protein isoforms, Heh1S and Heh1L, was monitored by western blot assays. <italic>HEH1</italic> gene was either ectopically expressed under a heterologous promoter from a plasmid, or chromosomally epitope-tagged at the N-terminus, in deletion and point mutants of splicing factors. Complementing the findings from the reporter assays, Heh1S protein was strongly diminished in the knockout mutants of Snu17, Bud13, Pml1, and Urn1, in addition to Hub1 (<xref ref-type="supplementary-material" rid="SD1">Figure S1d</xref>). The loss of potential RNA-binding residues of Hub1, as deduced from cryo-EM studies of spliceosomes<sup><xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R34">34</xref></sup>, showed a similar lack of Heh1S protein (<xref ref-type="supplementary-material" rid="SD1">Figure S1h</xref>). As expected, the previously reported D22A and H63L mutants of Hub1 were defective in <italic>HEH1</italic> alternative splicing. Hub1-binding deficient Snu66-HIND mutants also showed a lack of Heh1S (<xref ref-type="supplementary-material" rid="SD1">Figure S1j</xref>). A set of distinct Prp8 alleles was screened for alternative splicing defects by expressing <italic>HEH1</italic> gene from a plasmid with an N-terminal epitope tag. Interestingly, Heh1S protein was diminished specifically in the <italic>prp8-101</italic> (E1960K) allele<sup><xref ref-type="bibr" rid="R35">35</xref></sup>isoforms in mutants identified above are placed in (<xref ref-type="fig" rid="F1">Figure 1a</xref>). While Heh1S protein was strongly diminished in all the mutants than the wt strain, Heh1L isoform was higher in the mutants (<xref ref-type="fig" rid="F1">Figure 1a</xref>), possibly because the lack of competition from the <italic>HEH1S</italic> 5’SS site led to preferential usage of the dominant <italic>HEH1L</italic> 5’SS</p><p id="P11"><italic>(iii) HEH1 mRNA isoforms</italic>: <italic>HEH1</italic> transcripts were monitored by reverse-transcription (RT) PCR assays with primers binding in <italic>HEH1</italic> exons. More retention of intron was observed in Δ<italic>hub1</italic> and Δ<italic>snu66</italic> mutants compared to Δ<italic>ecm2, prp8-101</italic>, and the RES factor mutants (<xref ref-type="fig" rid="F1">Figure 1b</xref>). The data indicated normal constitutive splicing and enhanced usage of the dominant 5’SS in the absence the competing one in the mutants. We verified these observations by purifying and sequencing <italic>HEH1</italic> cDNAs from the mutants. Since <italic>HEH1S</italic> and <italic>HEH1L</italic> mRNAs differ in GCAA nucleotides at their exon junctions (<italic>HEHL</italic> gains them due to the usage of downstream 5’SS), the electropherogram shows two mixed peaks after the common exon. Areas under the peaks were integrated to estimate the relative abundance of the two mRNAs. Consistent with the above findings from reporter assays and protein analysis, the mutants showed diminished levels of <italic>HEH1S</italic> mRNA, confirming the 5’SS selection defects at the RNA level (<xref ref-type="fig" rid="F1">Figure 1c</xref>). The electropherograms further showed that <italic>HEH1L</italic> mRNA level was more in the mutants compared to the wt strain (<xref ref-type="fig" rid="F1">Figure 1d</xref>), consistent with higher protein levels seen in <xref ref-type="fig" rid="F1">Figure 1a</xref>. Thus, spliceosomes used the dominant <italic>HEH1L</italic> 5’SS more efficiently in the absence of competition from <italic>HEH1S</italic> 5’SS.</p><p id="P12"><italic>(iV)Probing hub1 proximity to splicing factors</italic>: In cells deleted of Hub1, Snu66-binding-deficient <italic>hub1(D22A)</italic> mutant in free form does not support the usage of <italic>HEH1</italic> alternative 5’SS, but its linear fusion to Snu66, Prp38 and Prp8 restored alternative splicing<sup><xref ref-type="bibr" rid="R28">28</xref></sup>. We used this strategy to find Hub1’s proximity to splicing factors essential for cell viability, which could not be analysed in the above assays. Interestingly, <italic>hub1(D22A)</italic> fused to Prp3, Prp6, and Prp31 visibly restored <italic>HEH1</italic> alternative splicing (<xref ref-type="fig" rid="F1">Figure 1e</xref>). Notably, proximities to only specific proteins of the spliceosome B<sup><xref ref-type="bibr" rid="R36">36</xref></sup> and Bact complexes<sup><xref ref-type="bibr" rid="R37">37</xref></sup> (Snu66, Prp38, Prp8, Prp3, Prp6, and Prp31), but not to other proteins of the B complex or the proteins of U1 and U2 snRNPs, restored alternative splicing (<xref ref-type="fig" rid="F1">Figure 1e</xref>).</p><p id="P13">The data discussed above in (i-iv) confirmed the role of specific proteins of the spliceosome core in <italic>HEH1</italic> alternative splicing. Interestingly, these factors did not lead to dominant usage of the alternative 5’SS. Overexpression of none of these proteins forced 5’SS selection towards the weaker 5’SS or suppressed the splicing from the dominant 5’SS (<xref ref-type="supplementary-material" rid="SD1">Figure S1m-n</xref>). Even double chromosomal fusions of <italic>hub1(D22A)</italic> to both Snu66 and Prp38 did not enhance splicing from the weaker 5’SS or suppress the dominant 5’SS (<xref ref-type="supplementary-material" rid="SD1">Figure S1o</xref>). Thus, the trans-acting proteins play critical roles in 5’SS selection, but do not dominate over the cis elements in the pre-mRNA. These findings raised an interesting question: if not by proteins, how are the competing 5’SS decoded?</p></sec><sec id="S4"><title>U5 and U6 snRNAs decode exon-intron boundaries for alternative 5’SS selection</title><p id="P14">From alternative splicing reporters discussed above and known binding sites of U1, U5, and U6 snRNAs at exon-intron boundaries, we narrowed a 16-nucleotide pre-mRNA segment (1913-1928 of <italic>HEH1</italic> gene) critical for alternative 5’SS selection (<xref ref-type="fig" rid="F2">Figure 2a</xref>). To study their importance, <italic>HEH1</italic> expression constructs containing changes at every nucleotide (except for the 5’ donors ‘G’) were made by site-directed mutagenesis. Proteins originating from the pre-mRNA variants were studied by western blots (<xref ref-type="fig" rid="F2">Figure 2b</xref>), and mRNA isoforms by cDNA sequencing (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Changes resulting in stop codons could be studied only by cDNA sequencing (for example, G<underline>C</underline>AA to G<underline>U</underline>AA change gains an in-frame stop codon in <italic>HEH1L</italic> mRNA, explaining why a GC donor instead of the common GU is used in <italic>HEH1</italic>). Almost any change in this region produced either Heh1S or Heh1L protein (barring the <italic>HEH1S</italic>•{G(−1)A} variant 4). These results highlighted the importance of precisely selected nucleotides around competing 5’SS for alternative splicing.</p><p id="P15">The loss of alternative splicing of the pre-mRNA variants, however, did not correlate with U1 snRNA-5’SS interaction. Strikingly, we noticed a perfect correlation in the 5’SS choice and base-pairing strengths with U5 and U6 snRNAs. 5’SS that paired stronger to U5 or U6 snRNAs appeared to be preferentially used as the donor site and led to the loss of splicing from the second site. These observations underlined the role of the spliceosome core with U5 and U6 snRNAs in 5’SS selection. These results also suggested potential competition of the two 5’SS for binding to U5 and U6 snRNAs, and only optimal pairing strengths would allow selection of both 5’SS. Extending this idea, U5 and U6 snRNA variants with modified pairing strengths should change 5’SS selection. We tested this possibility by overexpressing U1, U5, and U6 snRNA variants with reinforced pairing to the weaker 5’SS, and monitored the alternative splicing pattern by RNA and protein assays (<xref ref-type="fig" rid="F3">Figure 3b-c</xref> and <xref ref-type="supplementary-material" rid="SD1">Figure S3a-d</xref>).</p><p id="P16">Strengthened pairing of U5 and U6 snRNAs to a 5’SS favoured its selection. Stronger pairing of U(98)G variant of U5 snRNA and A(45)G variant of U6 snRNA to <italic>HEH1L</italic> 5’SS produced more Heh1L protein (<xref ref-type="supplementary-material" rid="SD1">Figure S3b and S3e</xref>). On the other hand, stronger pairing of U(98)C variant of U5 snRNA and U(46)C A(45)U variant of U6 snRNA variants to <italic>HEH1S</italic> 5’SS induced its preferential selection and produced more <italic>HEH1S</italic> mRNA and Heh1S protein (<xref ref-type="fig" rid="F3">Figure 3b-c</xref> and <xref ref-type="supplementary-material" rid="SD1">S3b and S3d</xref>). Furthermore, pairing of 46<sup>th</sup> and 45<sup>th</sup> nucleotides of U6 snRNA, beyond the ACAGA box, to +7 and +8 nucleotides of the intron are crucial determinants for choosing a competing 5’SS (<xref ref-type="fig" rid="F3">Figure 3b-c</xref> and <xref ref-type="supplementary-material" rid="SD1">Figure S3d</xref>). As discussed in <xref ref-type="supplementary-material" rid="SD1">Figure S1</xref>, overexpression of the protein factors did not induce a similar bias in 5’SS selection. Thus, optimal decoding of competing 5’SS by U5 and U6 snRNAs appears to be the primary and dominant step in 5’SS selection, and the pre-mRNA-snRNA interactions seem to be supported by specific proteins of the spliceosome core. Considering this scenario, strengthened U5 and U6 snRNAs should promote alternative selection of certain 5’SS variants even in the absence of identified B and Bact proteins (see below).</p></sec><sec id="S5"><title>Alternative selection of certain competing 5’SS is independent of the protein factors</title><p id="P17">A pre-mRNA variant with upstream 5’SS /GCA<underline>U</underline>GU (no. 7) was preferentially selected in all mutant strains except for the <italic>prp8-101</italic> allele (<xref ref-type="fig" rid="F4">Figure 4b</xref> and <xref ref-type="supplementary-material" rid="SD1">S4b</xref>). Since +4U strongly pairs with U6 snRNA’s ACAGA box, these results suggested that the snRNA might have suppressed the selection defects. Non-selection of /GCA<underline>U</underline>GU in <italic>prp8-101</italic> allele appeared to be specific to the GC donor sites. We explored this possibility by assaying activities from the established <italic>ACT1−CUP1</italic> splicing reporter<sup><xref ref-type="bibr" rid="R38">38</xref></sup> with 5’SS variants /GCAAGU, /GCA<underline>U</underline>GU, and /G<underline>U</underline>A<underline>U</underline>GU. Interestingly, /GCA<underline>U</underline>GU was used efficiently in all mutants, except for Δ<italic>hub1</italic> and <italic>prp8-101</italic>. C(+2)U exchanged /G<underline>U</underline>A<underline>U</underline>GU made the 5’SS canonical and was efficiently used in all strains, including Δ<italic>hub1</italic> and <italic>prp8-101</italic> (<xref ref-type="fig" rid="F4">Figure 4c</xref>). Thus, <italic>prp8-101</italic> allele could not use 5’SS with ‘C’ at +2 position, leading to the loss of alternative splicing. Furthermore, splicing from +3C variant of 5’SS /GU<underline>C</underline>UGU was defective in Δ<italic>hub1, Δsnu66 and prp8-101</italic> strains (<xref ref-type="supplementary-material" rid="SD1">Figure S4e</xref>). Thus, Hub1, Snu66 and Prp8 E1960 surface promote selection of non-canonical 5’SS containing +2C and +3C.</p><p id="P18">Prp8 is reported to exist in two conformations to maintain equilibrium between the two catalytic steps of splicing. Thus, its opposing alleles rescue splicing defects in one another<sup><xref ref-type="bibr" rid="R39">39</xref></sup>. However, the defects in the first step allele <italic>prp8-101</italic> could not be explained by this mechanism, since a second step allele <italic>prp8-161</italic> did not restore 5’SS selection in <italic>prp8-101</italic> (<xref ref-type="supplementary-material" rid="SD1">Figure S4d</xref>).</p><p id="P19">To find competing 5’SS that would allow alternative splicing through U5 and U6 snRNAs, but without the need of the above-mentioned B and Bact proteins, we made additional pre-mRNA variants by changing more than one nucleotide and monitored their splicing pattern (<xref ref-type="supplementary-material" rid="SD1">Figure S2</xref>). Proteins expressed from twenty constructs revealed two variants of competing 5’SS that allowed alternative splicing not only in wild-type yeast but also in strains mutated for the B and Bact proteins. 5’SS pairing of U5 and U6 snRNAs was strengthened in the variant 18 containing two canonical 5’SS /G<underline>U</underline>A<underline>U</underline>/GU<underline>AU</underline>GU. The snRNAs’ pairing was recalibrated in variant 15, containing two non-canonical 5’SS /GCAA/GU<underline>AUA</underline>U. Both these variants allowed alternative splicing not only in cells lacking the protein factors but also in the <italic>prp8-101</italic> allele (<xref ref-type="fig" rid="F4">Figure 4b</xref> and <xref ref-type="supplementary-material" rid="SD1">S4b</xref>). In variant 18, the competing sites are canonical and are readily used without the need for protein factors. The efficient use of canonical 5’SS in the absence of the protein factors is further supported by <italic>HEH1−CUP1</italic> reporters (<xref ref-type="supplementary-material" rid="SD1">Figure S4f-h</xref>).</p></sec><sec id="S6"><title>U5 and U6 snRNAs can promote alternative 5’SS selection without the protein factors</title><p id="P20"><italic>HEH1S</italic> expression from /GCAA/GU<underline>AUA</underline>U (variant 15) in cells lacking the protein factors was intriguing, since changes in this variant were beyond the hexanucleotide /GCAAGU. The outcomes could be explained by two possibilities: (i) weakening of the dominant 5’SS /GUGAGU to /GU<underline>AUA</underline>U rebalanced the competition for the weaker site, or (ii) improved binding of +7U and +8A in /GCAAGU<underline>AU</underline> to U6 snRNA nucleotides U46 and A45. The data further validated the importance of these two positions of U6 snRNA for alternative splicing discussed in <xref ref-type="fig" rid="F3">Figure 3</xref>.</p><p id="P">We tested these possibilities by using two reporters: <italic>HEH1S−CUP1</italic> and <italic>HEH1L−CUP1</italic> (<xref ref-type="fig" rid="F5">Figure 5b</xref>). The protein factors-independent selection of <italic>HEH1S</italic> in /GCAAGU<underline>AU</underline>, whether due to rebalanced competition or enhanced U6 snRNA pairing, was studied by weakening <italic>HEH1L</italic> 5’SS into /GCAA/GUGAG<underline>A</underline> (variant 10; lacks potential <italic>HEH1S</italic>-U6 pairing at +7 and +8 positions) and /GCAA/GU<underline>AUAA</underline> (variant 20; enhances U6 pairing at +7 and +8 positions of <italic>HEH1S</italic>) (<xref ref-type="fig" rid="F5">Figure 5a and c</xref>). 5’SS selection in Δ<italic>hub1</italic> and <italic>prp8-101</italic> improved for reporters with enhanced U6 pairing at +7 and +8 positions of the 5’SS, although the defect was only partially restored in the latter. The 5’SS selection in Δ<italic>snu17, Δurn1</italic>, and Δ<italic>ecm2</italic>, on the other hand, was improved by both enhanced U6 snRNA pairing to <italic>HEH1S</italic> and weakening competition from <italic>HEH1L</italic> (<xref ref-type="fig" rid="F5">Figure 5d</xref>). These results suggested that Hub1 and Prp8 promote selection of 5’SS with +2C (<xref ref-type="fig" rid="F4">Figure 4c</xref>), likely by stabilising U6 snRNA (<xref ref-type="fig" rid="F5">Figure 5d</xref>). In addition, Snu17, Urn1, and Ecm2 likely act by stabilising U6 snRNA and also by promoting splicing from the weaker 5’SS present in the vicinity of a dominant one, possibly by improving detection of one another by U5 and U6 snRNAs.</p><p id="P21">If the protein factors acted by stabilising U5 and U6 snRNAs on the weaker 5’SS, expression of these snRNA variants with strengthened pairing to the alternative 5’SS should bypass the need for the protein factors. Such U5 and U6 snRNA variants were identified above (<xref ref-type="fig" rid="F3">Figure 3</xref>) for their ability to bind strongly to <italic>HEH1S</italic> 5’SS and promote its competitive selection over the dominant <italic>HEH1L</italic> 5’SS. We tested whether these snRNA variants would also promote a similar preference for <italic>HEH1S</italic> 5’SS in cells lacking the protein factors. Expression of U5 snRNA U(98)C and U6 snRNA U(46)C,A(45)U variants from multicopy plasmids restored alternative splicing defects in Δ<italic>hub1, Δsnu17, Δecm2</italic> and Δ<italic>urn1</italic> mutants. The defect was also restored, albeit partially, in the <italic>prp8-101</italic> allele (<xref ref-type="fig" rid="F6">Figure 6</xref> and <xref ref-type="supplementary-material" rid="SD1">Figure S5b,d,e, and f</xref>). Despite improved recognition by U6 snRNA, partial rescue of <italic>HEH1S</italic> selection in the <italic>prp8-101</italic> mutants could be due to inefficient catalysis from +2C containing 5’SS (<xref ref-type="fig" rid="F4">Figure 4c</xref>).</p></sec></sec><sec id="S7" sec-type="discussion"><title>Discussion</title><p id="P22">Our findings, along with earlier reports, support a plausible mechanism of alternative 5’SS selection in B and Bact spliceosomes orchestrated by U5 and U6 snRNAs. Hub1 is likely recruited to the early B spliceosome through Snu66 and transferred to the MFAP1 (yeast Spp381) subunit of the Prp38 complex in the late B spliceosome. Core splicing factors centered around Prp8’s RH domain appears to play crucial roles in stabilizing the spliceosome on the alternative GC donor. The RES and NTC proteins promote competition for the alternative 5’SS, possibly from the Bact complex (<xref ref-type="fig" rid="F6">Figure 6c</xref>).</p><sec id="S8"><title>Pre-mRNA-snRNA interactions in alternative 5’SS selection</title><p id="P23">The data presented in this study support a dominant role of U5 and U6 snRNAs and a regulatory role of B and Bact proteins in alternative 5’SS selection. Early in the splicing cycle, U1 snRNP is paired at the 5′SS until the pre-B complex. U1 snRNA and associated factors have been reported to promote alternative 5’SS selection<sup><xref ref-type="bibr" rid="R40">40</xref></sup>. However, we could not find a role of U1 snRNPs and spliceosomes before the pre-B stage in alternative splicing from <italic>HEH1</italic>-type introns. At the B stage of spliceosome assembly, U1 snRNA hands over 5’SS to U6 snRNA. The ACAGA box of U6 base pairs with +3 to +6 nucleotides of the 5’SS. At the same time, U5 snRNA’s loop 1 base pairs with the upstream four nucleotides of the exon<sup><xref ref-type="bibr" rid="R41">41</xref></sup>.</p><p id="P24">U5 and U6 snRNAs were essential for alternative 5’SS selection. The defects in the mutants of the B and Bact complexes were suppressed by overexpression of U5 and U6 variants. At the same time, certain pre-mRNA variants with recalibrated pairing to the competing 5’SS were alternatively spliced in the absence of the protein factors. The marking of the target pre-mRNA by these snRNAs in the B complex allows U4/U6 snRNA unwinding and the formation of U2/U6 snRNA pair in the Bact complex<sup><xref ref-type="bibr" rid="R42">42</xref></sup>. These steps will define the branching site for the first catalytic step for +2C containing 5’SS in the B* complex<sup><xref ref-type="bibr" rid="R43">43</xref></sup>. Thus, the selection of the alternative 5’SS revolves around their recognition by U5 and U6 snRNAs.</p></sec><sec id="S9"><title>Specific B and Bact proteins facilitate alternative 5’SS selection</title><p id="P25">The trans-acting proteins critical for the alternative selection of 5’SS found in this study and reported earlier<sup><xref ref-type="bibr" rid="R28">28</xref></sup> belong to the spliceosome B or Bact complexes. Importantly, alternative 5’SS of <italic>HEH1</italic> is the first <italic>in vivo</italic> target of these factors, including the <italic>prp8-101</italic> allele, in <italic>S. cerevisiae</italic>. Splicing from the dominant 5’SS did not require these proteins. The protein factors appear to promote alternative 5’SS selection by stabilizing the spliceosome in a low-fidelity, high-efficiency conformation. These proteins promote alternative 5’SS selection at the expense of the dominant 5’SS. Supporting this notion, Hub1 has been reported to promote error-prone splicing and usage of non-canonical 5’SS<sup><xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref></sup>. The RES complex proteins Snu17, Bud13, and Urn1 promote non-canonical splicing<sup><xref ref-type="bibr" rid="R44">44</xref>–<xref ref-type="bibr" rid="R46">46</xref></sup>. Ecm2, on the other hand, is known to promote selection of non-canonical as well as competing 5’SS<sup><xref ref-type="bibr" rid="R32">32</xref></sup>.</p><p id="P26"><italic>A unique Prp8 allele and its role in 5’SS selection</italic>: Among the 14 distinct Prp8 alleles<sup><xref ref-type="bibr" rid="R47">47</xref></sup> tested in this study, the <italic>prp8-101</italic> (E1960K) allele was defective in alternative 5’SS selection. The mutation lies in its RNaseH/RH domain. The Prp8 RH domain toggles between transitional and catalytic conformations<sup><xref ref-type="bibr" rid="R48">48</xref></sup>. Till the B complex, it remains in a partially closed conformation and promotes fidelity over splicing efficiency. Its first step alleles<sup><xref ref-type="bibr" rid="R49">49</xref></sup> and Prp38<sup><xref ref-type="bibr" rid="R50">50</xref></sup> have been shown to stabilize the high-fidelity conformation. The defective splicing in <italic>prp8-101</italic> from +2C and +3C containing 5’SS, suggests high-fidelity feature of this mutant and the role of Prp8 in the usage of +2C and +3C containing 5’SS. The RH domain switches to a completely closed conformation in the Bact complex<sup><xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R51">51</xref></sup> and positions the RNA for first-step catalysis. Thus, conformational change during B to Bact transition appears to be critical for <italic>HEH1</italic> alternative splicing.</p><p id="P27"><italic>Prp3, Prp6 and Prp31</italic>: The Role of these proteins was identified through proximity probing with Hub1. These proteins surround the core Prp8 and show a major switch during the conversion of pre-B to B. The 180° shift in the RH domain from pre-B to B, along with tri-snRNP factors, is important for the recognition of alternative 5’SS<sup><xref ref-type="bibr" rid="R52">52</xref>,<xref ref-type="bibr" rid="R53">53</xref></sup>.</p><p id="P28"><italic>A new surface of the ubiquitin-like protein Hub1 for 5’SS selection</italic>: Hub1 joins the complex through non-covalent binding to Snu66. The Prp38 complex proteins Prp38, Snu13 and Spp381/MFAP1, associate with the tri-snRNP and help stabilise the B complex. The D22A surface of Hub1 is reported to bind Snu66 across eukaryotes <sup><xref ref-type="bibr" rid="R28">28</xref>,<xref ref-type="bibr" rid="R54">54</xref>,<xref ref-type="bibr" rid="R55">55</xref></sup>. The same surface binds MFAP1 in the human B spliceosome<sup><xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R56">56</xref></sup>. An additional Hub1 surface, N7 and K13, that binds the 5’ exon at -3 and -4 positions in human spliceosomes, was also critical for the alternative 5’SS selection in yeast<sup><xref ref-type="bibr" rid="R56">56</xref></sup>. D21 of Hub1 also interacts with the same surface of MFAP1<sup><xref ref-type="bibr" rid="R53">53</xref></sup>. Thus, Hub1 is possibly recruited to the early B complex through HIND domains in Snu66<sup><xref ref-type="bibr" rid="R28">28</xref></sup> and may promote alternative 5’SS selection through MFAP1 and RNA interactions in the mature B complex<sup><xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R56">56</xref></sup>. The RES complex proteins are present during the transition of the B to the Bact<sup><xref ref-type="bibr" rid="R31">31</xref></sup>.</p><p id="P29"><italic>The Bact complex</italic>: Brr2 helicase unwinds the U4/U6 duplex, triggering the release of U4 snRNP and the associated proteins (Prp3, Prp6, Prp31, Snu66, Hub1). Prp38 complex is also released at this stage, a key step for full activation of the spliceosome. U6 snRNA forms new interactions with U2 snRNA, assembling the catalytic core. The NTC protein Ecm2 and the RES complex proteins are associated with the Bact complex, highlighting the role of the RES in the remodelling of Bact via Prp2<sup><xref ref-type="bibr" rid="R51">51</xref></sup>. The RES complex leaves the spliceosome during Bact to B* conversion. All these proteins are important for alternative 5’SS selection.</p><p id="P30">In conclusion, yeast <italic>HEH1/SRC1</italic> pre-mRNA has proven to be an important tool for understanding alternative splicing through competing and partially overlapping 5’SS. U5 and U6 snRNAs are primary determinants for alternative 5’SS selection. Splicing factors promoting usage of the weak 5’SS reported previously (Hub1, Snu66, Prp38, Prp8), and the ones identified in this study (the B complex proteins Prp3, Prp6, Prp31, and Snu66; the RES complex subunits Bud13, Snu17, Pml1 and Urn1, and the NTC complex (Ecm2), are known to associate with the B or Bact spliceosomes. U5 and U6 snRNAs are essential components of both these assemblies. They pair with target pre-mRNA for alternative 5’SS selection with the help of the above trans-acting proteins.</p></sec></sec><sec id="S10"><title>Limitations of the Study</title><p id="P31">The study is supported by approaches of molecular biology, biochemistry and yeast genetics. Atomic details will need spliceosome structures during alternative 5’SS selection. <italic>prp8-101</italic>, containing spliceosome assembled on the alternative 5’SS with +2C, will refine the role of the catalytic core.</p></sec><sec id="S11"><title>Resource Availability</title><p id="P32">A.K.B. or S.K.M. may be contacted for resources used in this study.</p></sec><sec id="S12"><title>Star Method</title><sec id="S13"><title>Key Resource Table</title><table-wrap id="T4" orientation="portrait" position="anchor"><table frame="box" rules="all"><thead><tr><th valign="top" align="left">Reagent</th><th valign="top" align="left">Resource</th><th valign="top" align="left">Identifier</th></tr></thead><tbody><tr><td valign="top" align="left">Rabbit polyclonal anti-c-myc antibody</td><td valign="top" align="left">Sigma Aldrich</td><td valign="top" align="left">C3956</td></tr><tr><td valign="top" align="left">Rabbit Peroxidase anti-peroxidase soluble antibody</td><td valign="top" align="left">Sigma Aldrich</td><td valign="top" align="left">A0545</td></tr><tr><td valign="top" align="left">Goat anti-rabbit IgG peroxidase antibody</td><td valign="top" align="left">Sigma Aldrich</td><td valign="top" align="left">P1291</td></tr><tr><td valign="top" align="left">High-Capacity cDNA Reverse<break/>Transcription Kit</td><td valign="top" align="left">Applied<break/>Biosystem</td><td valign="top" align="left">4368813</td></tr><tr><td valign="top" align="left">NuPAGE™ Bis-Tris Mini Protein<break/>Gels, 4−12%</td><td valign="top" align="left">Invitrogen™</td><td valign="top" align="left">NP0323BOX</td></tr><tr><td valign="top" align="left">RQ1 RNase-Free DNase</td><td valign="top" align="left">Promega</td><td valign="top" align="left">M610A</td></tr><tr><td valign="top" align="left">Zymo-Spin II Columns</td><td valign="top" align="left">Zymo Research</td><td valign="top" align="left">C1008-250</td></tr><tr><td valign="top" align="left">Vent DNA polymerase</td><td valign="top" align="left">NEB</td><td valign="top" align="left">M0254L</td></tr><tr><td valign="top" align="left" colspan="3"><bold>Softwares</bold></td></tr><tr><td valign="top" align="left">Fiji-windows 64</td><td valign="top" align="left">NIH</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://imagej.net/software/fiji">https://imagej.net/software/fiji</ext-link></td></tr><tr><td valign="top" align="left">AlphaFold3</td><td valign="top" align="left">DeepMind<break/>(Google)</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://alphafoldserver.com/">https://alphafoldserver.com/</ext-link></td></tr></tbody></table></table-wrap></sec></sec><sec id="S14"><title>Method Details</title><sec id="S15"><title>Plasmids, yeast strains, <italic>S. cerevisiae</italic> transformation, and growth assays</title><p id="P33">Plasmids and strains used in this study are listed in <xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="table" rid="T2">Table 2</xref>, respectively. The yJU75 yeast strain, plasmids <italic>PRP8</italic> and <italic>prp8-101</italic>, and <italic>ACT1−CUP1</italic> reporter were kind gifts from C. Guthrie and M. Konarska’s lab. Prp8 mutant strains were made by shuffling out the Ura+ <italic>PRP8</italic> wildtype plasmid with the Trp+ <italic>prp8</italic> mutants on 5-fluoroorotic acid (FOA) plates. <italic>The S. cerevisiae</italic> deletion strains of splicing factors were obtained from the Euroscarf haploid deletion library. Competent cell preparation and transformation were performed following previously published protocols.<sup><xref ref-type="bibr" rid="R57">57</xref>,<xref ref-type="bibr" rid="R58">58</xref></sup>. Chromosomal tagging for western blot, double knockout strains for genetic interactions, and splicing factors deletion in the yJU75 background were made by using the reported protocol.<sup><xref ref-type="bibr" rid="R57">57</xref>,<xref ref-type="bibr" rid="R58">58</xref></sup>. Protein overexpression was achieved by expressing clones under a strong <italic>gal promoter</italic>. For growth/spot assays, 5-fold serial dilutions of cells were spotted on the indicated agar plates, and plates were incubated at temperatures indicated in the figure.</p></sec><sec id="S16"><title>Chromosomal fusion of <italic>hub1</italic>−<italic>D22A</italic> to the C-termini of splicing factors</title><p id="P34">Splicing by Overlap Extension (SOE) PCR was done to make <italic>hub1(D22A)</italic> C-terminal fusion to essential splicing factors. This fusion was done based on the published protocol<sup><xref ref-type="bibr" rid="R57">57</xref></sup>. Three sets of primers were used to amplify three fragments. First set of primers amplified a 200-300 bp fragment of the C termini of the desired gene, excluding the stop codon. The reverse primer of this had an overhang of 20-25 bps that was complementary to the 20-25 bps of <italic>hub1(D22A)</italic> N-terminus. The second set of primers amplified the full-length <italic>hub1(D22A)</italic> with the Nat antibiotic selection marker cassette from the plasmid clones of pFA6a-<italic>hub1(D22A)-natNT2</italic>. The third set of primers amplified a fragment of 200-300 bp from the stop codon of the gene that was going to be tagged. The forward primer for this had an overhang of 20-25 bp with the end of the antibiotic-resistance marker. All three fragments were amplified using Vent DNA polymerase. These fragments were confirmed based on their size on the agarose gel and the correct fragments were gel-purified. All three fragments were mixed and joined by SOE PCR using Vent DNA polymerase using the forward primer of the first fragment and the reverse primer of the third fragment. The joined fragment was confirmed by agarose gel electrophoresis and transformed into the <italic>S. cerevisiae</italic> strain. The transformants were selected on agar plates with antibiotic. The chromosomal fusion was confirmed by colony PCR using a forward primer specific to the gene and a reverse primer specific to the antibiotic cassette.</p></sec><sec id="S17"><title>Splicing reporters</title><p id="P35">The splicing reporters used in this study are listed in <xref ref-type="table" rid="T3">Table 3</xref>. Splicing reporters are modified forms of the conventional <italic>ACT1−CUP1</italic><sup><xref ref-type="bibr" rid="R38">38</xref></sup> and <italic>RP51−LACZ</italic><sup><xref ref-type="bibr" rid="R30">30</xref></sup>. The <italic>HEH1S−CUP1 reporters have a 121 bp segment of the S. cerevisiae HEH1</italic> gene (1874-2095 nucleotides), including the intron, using BamHI and KpnI restriction sites. The <italic>HEH1S</italic> mRNA is spliced using GCAAGU 5’SS, generating in-frame <italic>CUP1</italic> mRNA for translation. The methionine initiation codon was introduced by inserting a point mutation at C1881G. Initiation codon and variants of the 5’SS were made by site-directed mutagenesis (SDM) using specific primers, and the change was confirmed using Sanger sequencing. For <italic>HEH1L−CUP1</italic> reporter, a 120 bp segment of the <italic>HEH1</italic> gene (1874-2094 nucleotides) was used to bring the <italic>HEH1L</italic> mRNA spliced using GUGAGU 5’SS in-frame with the <italic>CUP1</italic> gene. For reporter assays, competent cells from the <italic>S. cerevisiae</italic> strain yJU75 were transformed with the reporters, and transformants were selected in media lacking leucine. 1 OD<sub>600</sub> cells were spotted on solid media with different concentrations of CuSO<sub>4</sub>. The plates were incubated for 2-3 days at 30°C. Similarly, for <italic>HEH1−LACZ</italic> reporters, the <italic>RP51</italic> part of the <italic>RP51−LACZ</italic> reporter (gift from M. Rosbash) was replaced with a <italic>HEH1</italic> fragment of 399 bp (1792-2191 nucleotides) and 398 bp (1792-2190 nucleotides) to obtain <italic>HEH1S−LACZ</italic> and <italic>HEH1L−LACZ</italic> reporters, respectively.</p></sec><sec id="S18"><title>β-galactosidase assay</title><p id="P36">β-galactosidase activity was observed on both solid and liquid media. The X-gal overlay and the ONPG assay were performed by following published protocols<sup><xref ref-type="bibr" rid="R59">59</xref></sup>.</p></sec><sec id="S19"><title>RNA isolation and cDNA synthesis</title><p id="P37">RNA isolation and cDNA synthesis were done as described previously<sup><xref ref-type="bibr" rid="R60">60</xref></sup>. Briefly, five OD<sub>600</sub> cells in the log phase were harvested. Total RNA was isolated by the hot acid phenol method using 15 mL phase lock tubes for phase separation. Residual DNA was removed by treating RNA with DNase I for 15 min at room temperature, followed by RNA clean-up using a Zymo-Spin™ II column. cDNA synthesis from 2μg total RNA was done using reverse transcriptase (RT) and random-hexamer primers at 37°C for 2h. Splicing defects were monitored by detecting intron-containing transcripts or post-splicing mature transcripts using exonic primers across the intron and analysed by agarose gel electrophoresis. For cDNA sequencing, five identical PCR reactions were performed. The PCR products were pooled and kept overnight for precipitation after adding 2.5 times the volume of isopropanol and 1/10<sup>th</sup> the volume of 3M sodium acetate at -20°C. DNA was pelleted by centrifugation for 15 min at 4°C at maximum speed. The pellet was washed twice with 70% ethanol. Dried pellet was dissolved in 30μl of nuclease-free water, and 10μl of the DNA was sequenced by Sanger sequencing using a primer nested inside the forward primer used in amplification.</p></sec><sec id="S20"><title>Quantification of <italic>HEH1</italic> mRNA isoforms</title><p id="P38"><italic>HEH1</italic> alternative splicing was analysed using RT-PCR followed by cDNA sequencing. <italic>HEH1S</italic> and <italic>HEH1L</italic> mRNAs differ in GCAA nucleotides at their exon junctions (<italic>HEHL</italic> gains them due to the usage of downstream 5’SS), the electropherogram shows mixed peaks corresponding to the two isoforms after the exon-exon junction. The area under the peaks was integrated to find the relative abundance of the two mRNAs. Both common and isoform-specific peaks were analysed within the region corresponding to the 5’exon/intron boundary. To understand alternative 5’SS usage, common nucleotides after the junction in the two isoforms was excluded from further analysis. For each site, we recorded the nucleotide proportions possible for both the cDNAs and calculated the ratio between the two nucleotides, normalising their combined total to 100%. The average value of both forms is directly related to their respective 5’SS usage.</p><p id="P39">Relative expression of <italic>HEH1L</italic> in wild-type and yeast mutants was obtained from the cDNA electropherogram. The areas under 10 common and 10 mixed peaks (before and after the junction, respectively), were integrated and averaged. Similarly, an area under the peaks specific to <italic>HEH1L</italic> was integrated and averaged. The ratio of common and <italic>HEHL</italic> peaks for different strains was obtained. The fold difference in <italic>HEH1L</italic> expression in the mutants was calculated against the wildtype strain by dividing the average of the area under <italic>HEH1L</italic> peaks (after the junction) by the average of the area under common peaks (before the junction).</p></sec><sec id="S21"><title>Western blots</title><p id="P40">For protein western blots (immunoblotting), logarithmically growing cells equivalent to 2 OD<sub>600</sub> were harvested. Whole protein was extracted using the trichloroacetic acid (TCA) method<sup><xref ref-type="bibr" rid="R57">57</xref></sup>. Total proteins used for western blots were denatured by heating cells in a high urea buffer at 65°C for 15 min and then centrifuged. The soluble protein was separated on sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 8% gels, or NuPAGE™ 4%-12% Bis-Tris gels (Invitrogen), transferred to a polyvinylidene difluoride (PVDF) membrane, and probed with specific primary and secondary antibodies. Protein bands were quantified using ImageJ following the published method<sup><xref ref-type="bibr" rid="R61">61</xref></sup>.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Material</label><media xlink:href="EMS206357-supplement-Supplementary_Material.pdf" mimetype="application" mime-subtype="pdf" id="d2aAcHbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S22"><title>Acknowledgement</title><p>We thank Stefan Jentsch (MPI Biochemistry, Martinsried, Germany) for his support. The work in S.K.M. laboratory has been supported by IISER Mohali and the Centre for Protein Science Design and Engineering (CPSDE) of the Ministry of Human Resource and Development (MHRD), Government of India; the Max Planck Society, Germany; and the Wellcome Trust/DBT India Alliance Fellowship/grant awarded to S.K.M. A.K.B. was supported by ICMR fellowship and IISER Mohali. We acknowledge Anupa T. Anil and B. Mohapatra for their inputs and technical guidance.</p></ack><fn-group><fn fn-type="con" id="FN2"><p id="P41"><bold>Author Contribution</bold></p><p id="P42">S.K.M. initiated the study in the Jentsch laboratory at the MPI Biochemistry, Martinsried, Germany. All authors designed and performed the experiments and analysed the data. A.K.B. and S.K.M. collated the data and prepared the manuscript with inputs from all authors.</p></fn><fn fn-type="conflict" id="FN3"><p id="P43"><bold>Declaration of Interest</bold></p><p id="P44">The authors declare no conflict of interest.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>ME</given-names></name><name><surname>Charenton</surname><given-names>C</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name></person-group><article-title>Annual Review of Biochemistry RNA Splicing by the Spliceosome</article-title><year>2025</year><volume>01</volume><fpage>46</fpage><pub-id pub-id-type="pmid">31794245</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fica</surname><given-names>SM</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name></person-group><source>Cryo-electron microscopy snapshots of the spliceosome: Structural insights into a dynamic ribonucleoprotein machine</source><publisher-name>Nature Publishing Group</publisher-name><year>2017</year><pub-id pub-id-type="pmcid">PMC6386135</pub-id><pub-id pub-id-type="pmid">28981077</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.3463</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>Y-M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>L-F</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Min</surname><given-names>Q-H</given-names></name><name><surname>Yang</surname><given-names>W-M</given-names></name><etal/></person-group><article-title>Mechanism of alternative splicing and its regulation</article-title><source>Biomed Rep</source><year>2015</year><volume>3</volume><fpage>152</fpage><lpage>158</lpage><pub-id pub-id-type="pmcid">PMC4360811</pub-id><pub-id pub-id-type="pmid">25798239</pub-id><pub-id pub-id-type="doi">10.3892/br.2014.407</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Gu</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><source>Alternative splicing and cancer: a systematic review</source><publisher-name>Springer Nature</publisher-name><year>2021</year><pub-id pub-id-type="pmcid">PMC7902610</pub-id><pub-id pub-id-type="pmid">33623018</pub-id><pub-id pub-id-type="doi">10.1038/s41392-021-00486-7</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Roca</surname><given-names>X</given-names></name><name><surname>Krainer</surname><given-names>AR</given-names></name><name><surname>Eperon</surname><given-names>IC</given-names></name></person-group><source>Pick one, but be quick: 5′ splice sites and the problems of too many choices</source><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name><year>2013</year><pub-id pub-id-type="pmcid">PMC3566305</pub-id><pub-id pub-id-type="pmid">23348838</pub-id><pub-id pub-id-type="doi">10.1101/gad.209759.112</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>P</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name></person-group><article-title>Factors affecting splicing strength of yeast genes</article-title><source>Comp Funct Genomics</source><year>2011</year><volume>2011</volume><pub-id pub-id-type="pmcid">PMC3226532</pub-id><pub-id pub-id-type="pmid">22162666</pub-id><pub-id pub-id-type="doi">10.1155/2011/212146</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogozin</surname><given-names>IB</given-names></name><name><surname>Carmel</surname><given-names>L</given-names></name><name><surname>Csuros</surname><given-names>M</given-names></name><name><surname>Koonin</surname><given-names>EV</given-names></name></person-group><article-title>Origin and evolution of spliceosomal introns</article-title><year>2012</year><pub-id pub-id-type="pmcid">PMC3488318</pub-id><pub-id pub-id-type="pmid">22507701</pub-id><pub-id pub-id-type="doi">10.1186/1745-6150-7-11</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>MT</given-names></name><name><surname>Fica</surname><given-names>SM</given-names></name><name><surname>Simpson</surname><given-names>GG</given-names></name></person-group><source>RNA splicing: a split consensus reveals two major 5′ splice site classes</source><publisher-name>Royal Society Publishing</publisher-name><year>2025</year><pub-id pub-id-type="pmcid">PMC11732430</pub-id><pub-id pub-id-type="pmid">39809319</pub-id><pub-id pub-id-type="doi">10.1098/rsob.240293</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bortfeldt</surname><given-names>R</given-names></name><name><surname>Schindler</surname><given-names>S</given-names></name><name><surname>Szafranski</surname><given-names>K</given-names></name><name><surname>Schuster</surname><given-names>S</given-names></name><name><surname>Holste</surname><given-names>D</given-names></name></person-group><article-title>Comparative analysis of sequence features involved in the recognition of tandem splice sites</article-title><source>BMC Genomics</source><year>2008</year><volume>9</volume><pub-id pub-id-type="pmcid">PMC2423196</pub-id><pub-id pub-id-type="pmid">18447903</pub-id><pub-id pub-id-type="doi">10.1186/1471-2164-9-202</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>Y</given-names></name><name><surname>Fox-Walsh</surname><given-names>KL</given-names></name><name><surname>Baldi</surname><given-names>PF</given-names></name><name><surname>Hertel</surname><given-names>KJ</given-names></name></person-group><article-title>Genomic splice-site analysis reveals frequent alternative splicing close to the dominant splice site</article-title><source>RNA</source><year>2006</year><volume>12</volume><fpage>2047</fpage><lpage>2056</lpage><pub-id pub-id-type="pmcid">PMC1664720</pub-id><pub-id pub-id-type="pmid">17053087</pub-id><pub-id pub-id-type="doi">10.1261/rna.151106</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sibley</surname><given-names>CR</given-names></name><name><surname>Blazquez</surname><given-names>L</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name></person-group><source>Lessons from non-canonical splicing</source><publisher-name>Nature Publishing Group</publisher-name><year>2016</year><pub-id pub-id-type="pmcid">PMC5154377</pub-id><pub-id pub-id-type="pmid">27240813</pub-id><pub-id pub-id-type="doi">10.1038/nrg.2016.46</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Navarro</surname><given-names>S</given-names></name><name><surname>Carlos Igual</surname><given-names>J</given-names></name><name><surname>Pérez-Ortín</surname><given-names>JE</given-names></name></person-group><article-title>SRCI: An intron-containing yeast gene involved in sister chromatid segregation</article-title><source>Yeast</source><year>2002</year><volume>19</volume><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">11754482</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grund</surname><given-names>SE</given-names></name><name><surname>Fischer</surname><given-names>T</given-names></name><name><surname>Cabal</surname><given-names>GG</given-names></name><name><surname>Antúnez</surname><given-names>O</given-names></name><name><surname>Pérez-Ortín</surname><given-names>JE</given-names></name><name><surname>Hurt</surname><given-names>E</given-names></name></person-group><article-title>The inner nuclear membrane protein Src1 associates with subtelomeric genes and alters their regulated gene expression</article-title><source>Journal of Cell Biology</source><year>2008</year><volume>182</volume><fpage>897</fpage><lpage>910</lpage><pub-id pub-id-type="pmcid">PMC2528585</pub-id><pub-id pub-id-type="pmid">18762579</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200803098</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mekhail</surname><given-names>K</given-names></name><name><surname>Seebacher</surname><given-names>J</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Moazed</surname><given-names>D</given-names></name></person-group><article-title>Role for perinuclear chromosome tethering in maintenance of genome stability</article-title><source>Nature</source><year>2008</year><volume>456</volume><fpage>667</fpage><lpage>670</lpage><pub-id pub-id-type="pmcid">PMC2596277</pub-id><pub-id pub-id-type="pmid">18997772</pub-id><pub-id pub-id-type="doi">10.1038/nature07460</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiner</surname><given-names>SM</given-names></name><name><surname>Koo</surname><given-names>PK</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Mochrie</surname><given-names>SGJ</given-names></name><name><surname>King</surname><given-names>MC</given-names></name></person-group><article-title>The tethering of chromatin to the nuclear envelope supports nuclear mechanics</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><pub-id pub-id-type="pmcid">PMC4490570</pub-id><pub-id pub-id-type="pmid">26074052</pub-id><pub-id pub-id-type="doi">10.1038/ncomms8159</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capella</surname><given-names>M</given-names></name><name><surname>Caballero</surname><given-names>LM</given-names></name><name><surname>Pfander</surname><given-names>B</given-names></name><name><surname>Braun</surname><given-names>S</given-names></name><name><surname>Jentsch</surname><given-names>S</given-names></name></person-group><article-title>ESCRT recruitment by the S. Cerevisiae inner nuclear membrane protein Heh1 is regulated by hub1-mediated alternative splicing</article-title><source>J Cell Sci</source><year>2020</year><volume>133</volume><pub-id pub-id-type="pmid">33262311</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puig</surname><given-names>O</given-names></name><name><surname>Bragado-Nilsson</surname><given-names>E</given-names></name><name><surname>Koski</surname><given-names>T</given-names></name><name><surname>Séraphin</surname><given-names>B</given-names></name></person-group><article-title>The U1 snRNP-associated factor Luc7p affects 5′ splice site selection in yeast and human</article-title><source>Nucleic Acids Res</source><year>2007</year><volume>35</volume><fpage>5874</fpage><lpage>5885</lpage><pub-id pub-id-type="pmcid">PMC2034479</pub-id><pub-id pub-id-type="pmid">17726058</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkm505</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwer</surname><given-names>B</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Shuman</surname><given-names>S</given-names></name></person-group><article-title>Structure-function analysis of the 5′ end of yeast U1 snRNA highlights genetic interactions with the Msl5Mud2 branchpoint-binding complex and other spliceosome assembly factors</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>7485</fpage><lpage>7500</lpage><pub-id pub-id-type="pmcid">PMC3753624</pub-id><pub-id pub-id-type="pmid">23754852</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkt490</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rösel-Hillgärtner</surname><given-names>TD</given-names></name><name><surname>Hung</surname><given-names>LH</given-names></name><name><surname>Khrameeva</surname><given-names>E</given-names></name><name><surname>Le Querrec</surname><given-names>P</given-names></name><name><surname>Gelfand</surname><given-names>MS</given-names></name><name><surname>Bindereif</surname><given-names>A</given-names></name></person-group><article-title>A Novel Intra-U1 snRNP Cross-Regulation Mechanism: Alternative Splicing Switch Links U1C and U1-70K Expression</article-title><source>PLoS Genet</source><year>2013</year><volume>9</volume><pub-id pub-id-type="pmcid">PMC3798272</pub-id><pub-id pub-id-type="pmid">24146627</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003856</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Der Houven Van Oordt</surname><given-names>W</given-names></name><name><surname>Newton</surname><given-names>K</given-names></name><name><surname>Screaton</surname><given-names>GR</given-names></name><name><surname>Cáceres</surname><given-names>JF</given-names></name></person-group><article-title>Role of SR protein modular domains in alternative splicing specificity in vivo</article-title><year>2000</year><pub-id pub-id-type="pmcid">PMC115228</pub-id><pub-id pub-id-type="pmid">11121472</pub-id><pub-id pub-id-type="doi">10.1093/nar/28.24.4822</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eperon</surname><given-names>IC</given-names></name><name><surname>Makarova</surname><given-names>OV</given-names></name><name><surname>Mayeda Akila Munroe</surname><given-names>SH</given-names></name><name><surname>Cáceres</surname><given-names>JF</given-names></name><name><surname>Cáceres</surname><given-names>C</given-names></name><name><surname>Hayward</surname><given-names>DG</given-names></name><name><surname>Krainer</surname><given-names>AR</given-names></name></person-group><article-title>Selection of Alternative 5 Splice Sites: Role of U1 snRNP and Models for the Antagonistic Effects of SF2/ASF and hnRNP A1</article-title><year>2000</year><pub-id pub-id-type="pmcid">PMC102138</pub-id><pub-id pub-id-type="pmid">11046128</pub-id><pub-id pub-id-type="doi">10.1128/mcb.20.22.8303-8318.2000</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>SD</given-names></name><name><surname>Chakrabarti</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>G</given-names></name><name><surname>Krainer</surname><given-names>AR</given-names></name></person-group><article-title>Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing</article-title><source>PLoS One</source><year>2007</year><volume>2</volume><pub-id pub-id-type="pmcid">PMC1952110</pub-id><pub-id pub-id-type="pmid">17786225</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0000854</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Fu</surname><given-names>XD</given-names></name></person-group><article-title>Regulation of splicing by SR proteins and SR protein-specific kinases</article-title><year>2013</year><pub-id pub-id-type="pmcid">PMC3660409</pub-id><pub-id pub-id-type="pmid">23525660</pub-id><pub-id pub-id-type="doi">10.1007/s00412-013-0407-z</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandhu</surname><given-names>R</given-names></name><name><surname>Sinha</surname><given-names>A</given-names></name><name><surname>Montpetit</surname><given-names>B</given-names></name></person-group><article-title>The SR-protein Npl3 is an essential component of the meiotic splicing regulatory network in Saccharomyces cerevisiae</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><fpage>2552</fpage><lpage>2568</lpage><pub-id pub-id-type="pmcid">PMC7969001</pub-id><pub-id pub-id-type="pmid">33577675</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkab071</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinosa</surname><given-names>S</given-names></name><name><surname>De Bortoli</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Rossi</surname><given-names>J</given-names></name><name><surname>Wagley</surname><given-names>ME</given-names></name><name><surname>Lo</surname><given-names>H-YG</given-names></name><name><surname>Taliaferro</surname><given-names>JM</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name></person-group><article-title>Human PRPF39 is an alternative splicing factor recruiting U1 snRNP to weak 5 ′ ′ ′ ′ ′ splice sites</article-title><year>2023</year><pub-id pub-id-type="pmcid">PMC9808567</pub-id><pub-id pub-id-type="pmid">36316087</pub-id><pub-id pub-id-type="doi">10.1261/rna.079320.122</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogalska</surname><given-names>ME</given-names></name><name><surname>Mancini</surname><given-names>E</given-names></name><name><surname>Bonnal</surname><given-names>S</given-names></name><name><surname>Gohr</surname><given-names>A</given-names></name><name><surname>Dunyak</surname><given-names>BM</given-names></name><name><surname>Arecco</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>PG</given-names></name><name><surname>Vaillancourt</surname><given-names>FH</given-names></name><name><surname>Valcárcel</surname><given-names>J</given-names></name></person-group><article-title>Transcriptome-wide splicing network reveals specialized regulatory functions of the core spliceosome</article-title><year>2024</year><pub-id pub-id-type="pmid">39480945</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karaduman</surname><given-names>R</given-names></name><name><surname>Chanarat</surname><given-names>S</given-names></name><name><surname>Pfander</surname><given-names>B</given-names></name><name><surname>Jentsch</surname><given-names>S</given-names></name></person-group><article-title>Error-Prone Splicing Controlled by the Ubiquitin Relative Hub1</article-title><source>Mol Cell</source><year>2017</year><volume>67</volume><fpage>423</fpage><lpage>432</lpage><elocation-id>e4</elocation-id><pub-id pub-id-type="pmid">28712727</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>SK</given-names></name><name><surname>Ammon</surname><given-names>T</given-names></name><name><surname>Popowicz</surname><given-names>GM</given-names></name><name><surname>Krajewski</surname><given-names>M</given-names></name><name><surname>Nagel</surname><given-names>RJ</given-names></name><name><surname>Ares</surname><given-names>M</given-names></name><name><surname>Holak</surname><given-names>TA</given-names></name><name><surname>Jentsch</surname><given-names>S</given-names></name></person-group><article-title>Role of the ubiquitin-like protein Hub1 in splice-site usage and alternative splicing</article-title><source>Nature</source><year>2011</year><volume>474</volume><fpage>173</fpage><lpage>180</lpage><pub-id pub-id-type="pmcid">PMC3587138</pub-id><pub-id pub-id-type="pmid">21614000</pub-id><pub-id pub-id-type="doi">10.1038/nature10143</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chanarat</surname><given-names>S</given-names></name><name><surname>Mishra</surname><given-names>SK</given-names></name></person-group><source>Emerging Roles of Ubiquitin-like Proteins in Pre-mRNA Splicing</source><publisher-name>Elsevier Ltd</publisher-name><year>2018</year><pub-id pub-id-type="pmid">30269981</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacquier</surname><given-names>A</given-names></name><name><surname>Rodriguez</surname><given-names>JR</given-names></name><name><surname>Rosbash</surname><given-names>M</given-names></name></person-group><article-title>A Quantitative Analysis of the Effects of 5’ Junction and TACTAAC Box Mutants and Mutant Combinations on Yeast mRNA Splicing</article-title><year>1985</year><pub-id pub-id-type="pmid">3935321</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>P</given-names></name><name><surname>Will</surname><given-names>CL</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Boon</surname><given-names>KL</given-names></name><name><surname>Lührmann</surname><given-names>R</given-names></name></person-group><article-title>The RES complex is required for efficient transformation of the precatalytic B spliceosome into an activated Bact complex</article-title><source>Genes Dev</source><year>2017</year><volume>31</volume><fpage>2416</fpage><lpage>2429</lpage><pub-id pub-id-type="pmcid">PMC5795787</pub-id><pub-id pub-id-type="pmid">29330354</pub-id><pub-id pub-id-type="doi">10.1101/gad.308163.117</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Der Feltz</surname><given-names>C</given-names></name><name><surname>Nikolai</surname><given-names>B</given-names></name><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Paulson</surname><given-names>JC</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Hoskins</surname><given-names>AA</given-names></name></person-group><article-title>Saccharomyces cerevisiae Ecm2 modulates the catalytic steps of pre-mRNA splicing</article-title><year>2021</year><pub-id pub-id-type="pmcid">PMC8051269</pub-id><pub-id pub-id-type="pmid">33547186</pub-id><pub-id pub-id-type="doi">10.1261/rna.077727.120</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhan</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>R</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Structural insights into human exon-defined spliceosome prior to activation</article-title><source>Cell Res</source><year>2024</year><volume>34</volume><fpage>428</fpage><lpage>439</lpage><pub-id pub-id-type="pmcid">PMC11143319</pub-id><pub-id pub-id-type="pmid">38658629</pub-id><pub-id pub-id-type="doi">10.1038/s41422-024-00949-w</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Dybkov</surname><given-names>O</given-names></name><name><surname>Will</surname><given-names>CL</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Stark</surname><given-names>H</given-names></name><name><surname>Lührmann</surname><given-names>R</given-names></name></person-group><article-title>Cryo-EM analyses of dimerized spliceosomes provide new insights into the functions of B complex proteins</article-title><source>EMBO Journal</source><year>2024</year><volume>43</volume><fpage>1065</fpage><lpage>1088</lpage><pub-id pub-id-type="pmcid">PMC10943123</pub-id><pub-id pub-id-type="pmid">38383864</pub-id><pub-id pub-id-type="doi">10.1038/s44318-024-00052-1</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umen</surname><given-names>JG</given-names></name><name><surname>Guthrie</surname><given-names>C</given-names></name></person-group><article-title>A novel role for a U5 snRNP protein m 3’ splice site selecuon</article-title><pub-id pub-id-type="pmid">7535718</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>R</given-names></name><name><surname>Wan</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Structures of the fully assembled Saccharomyces cerevisiae spliceosome before activation</article-title><pub-id pub-id-type="pmid">29794219</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>R</given-names></name><name><surname>Bai</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Structures of the Catalytically Activated Yeast Spliceosome Reveal the Mechanism of Branching</article-title><source>Cell</source><year>2019</year><volume>177</volume><fpage>339</fpage><lpage>351</lpage><elocation-id>e13</elocation-id><pub-id pub-id-type="pmid">30879786</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesser</surname><given-names>CF</given-names></name><name><surname>Guthrie</surname><given-names>C</given-names></name></person-group><article-title>Mutational Analysis of pre-mRNA Splicing in Saccharomyces cerarisiae Using a Sensitive New Reporter Gene, CUPl</article-title><year>1993</year><pub-id pub-id-type="pmcid">PMC1205405</pub-id><pub-id pub-id-type="pmid">8462846</pub-id><pub-id pub-id-type="doi">10.1093/genetics/133.4.851</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Query</surname><given-names>CC</given-names></name><name><surname>Konarska</surname><given-names>MM</given-names></name></person-group><article-title>Opposing classes of prp8 alleles modulate the transition between the catalytic steps of pre-mRNA splicing</article-title><source>Nat Struct Mol Biol</source><year>2007</year><volume>14</volume><fpage>519</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">17486100</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Espinosa</surname><given-names>S</given-names></name><name><surname>Hill</surname><given-names>RC</given-names></name><name><surname>Hansen</surname><given-names>KC</given-names></name><name><surname>Zhou</surname><given-names>ZH</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name></person-group><article-title>CryoEM structure of Saccharomyces cerevisiae U1 snRNP offers insight into alternative splicing</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><pub-id pub-id-type="pmcid">PMC5648754</pub-id><pub-id pub-id-type="pmid">29051543</pub-id><pub-id pub-id-type="doi">10.1038/s41467-017-01241-9</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>R</given-names></name><name><surname>Wan</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Structures of the fully assembled Saccharomyces cerevisiae spliceosome before activation</article-title></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plaschka</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>PC</given-names></name><name><surname>Charenton</surname><given-names>C</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name></person-group><article-title>Prespliceosome structure provides insights into spliceosome assembly and regulation</article-title><source>Nature</source><year>2018</year><volume>559</volume><fpage>419</fpage><lpage>422</lpage><pub-id pub-id-type="pmcid">PMC6141012</pub-id><pub-id pub-id-type="pmid">29995849</pub-id><pub-id pub-id-type="doi">10.1038/s41586-018-0323-8</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plaschka</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>PC</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name></person-group><article-title>Structure of a pre-catalytic spliceosome</article-title><source>Nature</source><year>2017</year><volume>546</volume><fpage>617</fpage><lpage>621</lpage><pub-id pub-id-type="pmcid">PMC5503131</pub-id><pub-id pub-id-type="pmid">28530653</pub-id><pub-id pub-id-type="doi">10.1038/nature22799</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>MA</given-names></name><name><surname>Dziembowski</surname><given-names>A</given-names></name><name><surname>Quevillon-Cheruel</surname><given-names>S</given-names></name><name><surname>Henriot</surname><given-names>V</given-names></name><name><surname>Faux</surname><given-names>C</given-names></name><name><surname>Van Tilbeurgh</surname><given-names>H</given-names></name><name><surname>Séraphin</surname><given-names>B</given-names></name></person-group><article-title>Structure of the yeast Pml1 splicing factor and its integration into the RES complex</article-title><source>Nucleic Acids Res</source><year>2009</year><volume>37</volume><fpage>129</fpage><lpage>143</lpage><pub-id pub-id-type="pmcid">PMC2615620</pub-id><pub-id pub-id-type="pmid">19033360</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkn894</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottschalk</surname><given-names>A</given-names></name><name><surname>Bartels</surname><given-names>C</given-names></name><name><surname>Neubauer</surname><given-names>G</given-names></name><name><surname>Lührmann</surname><given-names>R</given-names></name><name><surname>Fabrizio</surname><given-names>P</given-names></name></person-group><article-title>A Novel Yeast U2 snRNP Protein, Snu17p, Is Required for the First Catalytic Step of Splicing and for Progression of Spliceosome Assembly</article-title><source>Mol Cell Biol</source><year>2001</year><volume>21</volume><fpage>3037</fpage><lpage>3046</lpage><pub-id pub-id-type="pmcid">PMC86932</pub-id><pub-id pub-id-type="pmid">11287609</pub-id><pub-id pub-id-type="doi">10.1128/MCB.21.9.3037-3046.2001</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dziembowski</surname><given-names>A</given-names></name><name><surname>Ventura</surname><given-names>AP</given-names></name><name><surname>Rutz</surname><given-names>B</given-names></name><name><surname>Caspary</surname><given-names>F</given-names></name><name><surname>Faux</surname><given-names>C</given-names></name><name><surname>Halgand</surname><given-names>F</given-names></name><name><surname>Laprévote</surname><given-names>O</given-names></name><name><surname>Séraphin</surname><given-names>B</given-names></name></person-group><article-title>Proteomic analysis identifies a new complex required for nuclear pre-mRNA retention and splicing</article-title><source>EMBO Journal</source><year>2004</year><volume>23</volume><fpage>4847</fpage><lpage>4856</lpage><pub-id pub-id-type="pmcid">PMC535094</pub-id><pub-id pub-id-type="pmid">15565172</pub-id><pub-id pub-id-type="doi">10.1038/sj.emboj.7600482</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galej</surname><given-names>WP</given-names></name><name><surname>Oubridge</surname><given-names>C</given-names></name><name><surname>Newman</surname><given-names>AJ</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name></person-group><article-title>Crystal structure of Prp8 reveals active site cavity of the spliceosome</article-title><source>Nature</source><year>2013</year><volume>493</volume><fpage>638</fpage><lpage>643</lpage><pub-id pub-id-type="pmcid">PMC3672837</pub-id><pub-id pub-id-type="pmid">23354046</pub-id><pub-id pub-id-type="doi">10.1038/nature11843</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayerle</surname><given-names>M</given-names></name><name><surname>Raghavan</surname><given-names>M</given-names></name><name><surname>Ledoux</surname><given-names>S</given-names></name><name><surname>Price</surname><given-names>A</given-names></name><name><surname>Stepankiw</surname><given-names>N</given-names></name><name><surname>Hadjivassiliou</surname><given-names>H</given-names></name><name><surname>Moehle</surname><given-names>EA</given-names></name><name><surname>Mendoza</surname><given-names>SD</given-names></name><name><surname>Pleiss</surname><given-names>JA</given-names></name><name><surname>Guthrie</surname><given-names>C</given-names></name><etal/></person-group><article-title>Structural toggle in the RNaseH domain of Prp8 helps balance splicing fidelity and catalytic efficiency</article-title><source>Proc Natl Acad Sci U S A</source><year>2017</year><volume>114</volume><fpage>4739</fpage><lpage>4744</lpage><pub-id pub-id-type="pmcid">PMC5422793</pub-id><pub-id pub-id-type="pmid">28416677</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1701462114</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schellenberg</surname><given-names>MJ</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Ritchie</surname><given-names>DB</given-names></name><name><surname>Fica</surname><given-names>S</given-names></name><name><surname>Staley</surname><given-names>JP</given-names></name><name><surname>Atta</surname><given-names>KA</given-names></name><name><surname>Lapointe</surname><given-names>P</given-names></name><name><surname>Macmillan</surname><given-names>AM</given-names></name></person-group><article-title>A conformational switch in PRP8 mediates metal ion coordination that promotes pre-mRNA exon ligation</article-title><source>Nat Struct Mol Biol</source><year>2013</year><volume>20</volume><fpage>728</fpage><lpage>734</lpage><pub-id pub-id-type="pmcid">PMC3703396</pub-id><pub-id pub-id-type="pmid">23686287</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.2556</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name></person-group><article-title>Survey and summary: Structural dynamics of the N-terminal domain and the Switch loop of Prp8 during spliceosome assembly and activation</article-title><source>Nucleic Acids Res</source><year>2018</year><volume>46</volume><fpage>3833</fpage><lpage>3840</lpage><pub-id pub-id-type="pmcid">PMC5934631</pub-id><pub-id pub-id-type="pmid">29635373</pub-id><pub-id pub-id-type="doi">10.1093/nar/gky242</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauhut</surname><given-names>R</given-names></name><name><surname>Fabrizio</surname><given-names>P</given-names></name><name><surname>Dybkov</surname><given-names>O</given-names></name><name><surname>Hartmuth</surname><given-names>K</given-names></name><name><surname>Pena</surname><given-names>V</given-names></name><name><surname>Chari</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Lee</surname><given-names>C-T</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Kastner</surname><given-names>B</given-names></name><etal/></person-group><article-title>Molecular architecture of the Saccharomyces cerevisiae activated spliceosome</article-title><pub-id pub-id-type="pmid">27562955</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>X</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Structures of the human pre-catalytic spliceosome and its precursor spliceosome</article-title><source>Cell Res</source><year>2018</year><volume>28</volume><fpage>1129</fpage><lpage>1140</lpage><pub-id pub-id-type="pmcid">PMC6274647</pub-id><pub-id pub-id-type="pmid">30315277</pub-id><pub-id pub-id-type="doi">10.1038/s41422-018-0094-7</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhan</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>R</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Structural insights into human exon-defined spliceosome prior to activation</article-title><source>Cell Res</source><year>2024</year><volume>34</volume><fpage>428</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1038/s41422-024-00949-w</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ammon</surname><given-names>T</given-names></name><name><surname>Mishra</surname><given-names>SK</given-names></name><name><surname>Kowalska</surname><given-names>K</given-names></name><name><surname>Popowicz</surname><given-names>GM</given-names></name><name><surname>Holak</surname><given-names>TA</given-names></name><name><surname>Jentsch</surname><given-names>S</given-names></name></person-group><article-title>The conserved ubiquitin-like protein Hub1 plays a critical role in splicing in human cells</article-title><year>2014</year><pub-id pub-id-type="pmcid">PMC4141198</pub-id><pub-id pub-id-type="pmid">24872507</pub-id><pub-id pub-id-type="doi">10.1093/jmcb/mju026</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolathur</surname><given-names>KK</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Kadam</surname><given-names>NY</given-names></name><name><surname>Shahi</surname><given-names>N</given-names></name><name><surname>Nishitha</surname><given-names>A</given-names></name><name><surname>Babu</surname><given-names>K</given-names></name><name><surname>Mishra</surname><given-names>SK</given-names></name></person-group><article-title>The ubiquitin-like protein Hub1/UBL-5 functions in pre-mRNA splicing in Caenorhabditis elegans</article-title><source>FEBS Lett</source><year>2023</year><volume>597</volume><fpage>448</fpage><lpage>457</lpage><pub-id pub-id-type="pmcid">PMC7615767</pub-id><pub-id pub-id-type="pmid">36480405</pub-id><pub-id pub-id-type="doi">10.1002/1873-3468.14555</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Dybkov</surname><given-names>O</given-names></name><name><surname>Will</surname><given-names>CL</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Stark</surname><given-names>H</given-names></name><name><surname>Lührmann</surname><given-names>R</given-names></name></person-group><article-title>Cryo-EM analyses of dimerized spliceosomes provide new insights into the functions of B complex proteins</article-title><source>EMBO Journal</source><year>2024</year><volume>43</volume><fpage>1065</fpage><lpage>1088</lpage><pub-id pub-id-type="doi">10.1038/s44318-024-00052-1</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janke</surname><given-names>C</given-names></name><name><surname>Magiera</surname><given-names>MM</given-names></name><name><surname>Rathfelder</surname><given-names>N</given-names></name><name><surname>Taxis</surname><given-names>C</given-names></name><name><surname>Reber</surname><given-names>S</given-names></name><name><surname>Maekawa</surname><given-names>H</given-names></name><name><surname>Moreno-Borchart</surname><given-names>A</given-names></name><name><surname>Doenges</surname><given-names>G</given-names></name><name><surname>Schwob</surname><given-names>E</given-names></name><name><surname>Schiebel</surname><given-names>E</given-names></name><etal/></person-group><article-title>A versatile toolbox for PCR-based tagging of yeast genes: New fluorescent proteins, more markers and promoter substitution cassettes</article-title><source>Yeast</source><year>2004</year><volume>21</volume><fpage>947</fpage><lpage>962</lpage><pub-id pub-id-type="pmid">15334558</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knop</surname><given-names>M</given-names></name><name><surname>Siegers</surname><given-names>K</given-names></name><name><surname>Pereira</surname><given-names>G</given-names></name><name><surname>Zachariae</surname><given-names>W</given-names></name><name><surname>Winsor</surname><given-names>B</given-names></name><name><surname>Nasmyth</surname><given-names>K</given-names></name><name><surname>Schiebel</surname><given-names>E</given-names></name></person-group><article-title>Epitope Tagging of Yeast Genes using a PCR-based Strategy: More Tags and Improved Practical Routines</article-title><year>1999</year><pub-id pub-id-type="pmid">10407276</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barral</surname><given-names>Y</given-names></name><name><surname>Jentsch</surname><given-names>S</given-names></name><name><surname>Mann</surname><given-names>C</given-names></name></person-group><article-title>cyclin turnover and nutrient uptake are controlled by a common pathway in yeast</article-title><pub-id pub-id-type="pmid">7883165</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inada</surname><given-names>M</given-names></name><name><surname>Pleiss</surname><given-names>JA</given-names></name></person-group><article-title>Genome-wide approaches to monitor pre-mrna splicing</article-title><source>Methods Enzymol</source><year>2010</year><volume>470</volume><fpage>51</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">20946806</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davarinejad</surname><given-names>H</given-names></name></person-group><article-title>Quantifications of Western Blots with ImageJ</article-title></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Wan</surname><given-names>R</given-names></name><name><surname>Bai</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Structure of a yeast activated spliceosome at 3.5 Åresolution</article-title><source>Science (1979)</source><year>2016</year><volume>353</volume><fpage>904</fpage><lpage>911</lpage><pub-id pub-id-type="pmid">27445306</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>THD</given-names></name><name><surname>Galej</surname><given-names>WP</given-names></name><name><surname>Bai</surname><given-names>XC</given-names></name><name><surname>Oubridge</surname><given-names>C</given-names></name><name><surname>Newman</surname><given-names>AJ</given-names></name><name><surname>Scheres</surname><given-names>SHW</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name></person-group><article-title>Cryo-EM structure of the yeast U4/U6.U5 tri-snRNP at 3.7 Åresolution</article-title><source>Nature</source><year>2016</year><volume>530</volume><fpage>298</fpage><lpage>302</lpage><pub-id pub-id-type="pmcid">PMC4762201</pub-id><pub-id pub-id-type="pmid">26829225</pub-id><pub-id pub-id-type="doi">10.1038/nature16940</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title><italic>HEH1</italic> alternative splicing needs B and Bact proteins.</title><p><bold>(a)</bold> The abundance of Heh1 L and S protein isoforms in the mutants of indicated spliceosomal proteins was monitored by western blots. Data shown as mean ± s.d. (n=3 independent replicates). <bold>(b)</bold> RT-PCR assays to monitor of <italic>HEH1</italic> pre-mRNA splicing in deletions and mutant strains of indicated splicing factors. <italic>hub1, snu17, ecm2</italic>, and <italic>urn1</italic> mutant strains are respective gene knockouts. <italic>snu66-AA</italic> mutant refers to R16A and R47A variant of Snu66, its Hub1-binding-deficient HIND mutant. <italic>prp8-101</italic> is the E1960K allele of Prp8. The mutants were identified from different targeted screens shown in <xref ref-type="supplementary-material" rid="SD1">Figure S1a-f, h-j</xref>, and <xref ref-type="supplementary-material" rid="SD1">k-l</xref>. <bold>(c)</bold>Spliced cDNA bands were purified from mutants in (b) and sequenced to estimate the extent of <italic>HEH1</italic> alternative splicing from the area under peaks of isoform-specific nucleotides. The values for UU<underline>A</underline>UCACC indicate the relative abundance of <italic>HEH1S</italic>, and GC<underline>A</underline>AUUAU shows the relative abundance of <italic>HEH1L</italic>. Peak for the underlined A, being common to both isoforms, were omitted from the quantitation. The values on the right of the peaks indicate relative % abundance of respective mRNA isoforms. <bold>(d)</bold> Relative abundance of <italic>HEH1L</italic> mRNA in different strains was estimated from cDNA electropherogram (shown in <xref ref-type="fig" rid="F1">Figure 1c</xref>) <bold>(e)</bold> Splicing factors from distinct spliceosomal complexes were probed by linear chromosomal fusions of a Snu66-binding-deficient <italic>hub1(D22A)</italic> mutant, indicated with ◯, at the C-termini of respective splicing factors. Rescue of alternative splicing defects (Heh1S protein) in the Δ<italic>hub1</italic> background following <italic>hub1(D22A)</italic> fusion was monitored in western blots. Upward triangle (▴) marks Δ<italic>hub1</italic> strain harboring splicing factor-<italic>hub1(D22A)</italic> fusions, where Heh1S protein were restored. Note that the otherwise free <italic>hub1(D22A)</italic> is deficient in <italic>HEH1</italic> alternative splicing<sup><xref ref-type="bibr" rid="R28">28</xref></sup> (see <xref ref-type="supplementary-material" rid="SD1">Figure S1h</xref>).</p></caption><graphic xlink:href="EMS206357-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Sequence at the exon-intron boundary determines alternative 5’SS selection.</title><p><bold>(a)</bold> The 16 nucleotides segment at the exon/intron (1913-1926) boundary of <italic>HEH1</italic> was investigated for alternative splicing. The sequence was selected based on reporter assays described earlier, pairing of U5 snRNA loop1 and U6 snRNA ACAGA box. <italic>HEH1S</italic> (orange color) and <italic>HEH1L</italic> (red color) sequences represent isoforms of <italic>HEH1</italic> pre-mRNA. <bold>(b)</bold> <italic>HEH1</italic> was mutated sequentially from left to right and alternative selection was monitored by western blot. Data shown as mean ± s.d. (n=3 independent repeats). <bold>(c)</bold> Analysis of pre-mRNA variants paring with U5 snRNA (Blue) and U6 snRNA (Green) for both <italic>HEH1S</italic> and <italic>HEH1L</italic> was tabulated. The mutants were analyzed for presumed U5 and U6 snRNA pairings adapted from<sup><xref ref-type="bibr" rid="R37">37</xref>,<xref ref-type="bibr" rid="R62">62</xref></sup>. Western blot lanes are taken from (b). The number in the left column shows variants ID. Resulting changes for <italic>HEH1S</italic> and <italic>HEH1L</italic> are shown in curly brackets {}. Filled dots (•) shows non-Watson-Crick pairing, standing lines (<bold>i</bold>) represent Watson-Crick pairing, upward arrows (↑) mean increase in U5 / U6 pairing compared to WT <italic>HEH1S</italic> or <italic>HEH1L</italic>, downward arrows (↓) show decrease in U5 / U6 pairing compared to WT. and double upward arrows (↑↑) represent the yeast canonical 5’SS (GUAUGU or GUAAGU. The variants leading to premature stop codons, indicated by asterisk (*), could be analysed only by cDNA sequencing. The values on the right of the peaks indicate relative % abundance of respective mRNA isoforms.</p></caption><graphic xlink:href="EMS206357-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Role of U5/U6 pairing in <italic>HEH1</italic> alternative splicing.</title><p><bold>(a)</bold> The pairing of U5 snRNA and its variant U5•{U(98)C} and U6 snRNA and its variant U6•{A(45)U,U(46)C} to <italic>HEH1</italic> pre-mRNAs. The snRNA variants were identified (<xref ref-type="supplementary-material" rid="SD1">Figure S3a-b and S3c-d</xref>) by mutagenesis of U5 Loop1 and U6 ACAGA box. Up/down arrows (↑/↓) refer to increase/decrease in U5/U6 pairing to <italic>HEH1</italic> isoforms. <bold>(b)</bold> <italic>HEH1</italic> cDNAs from yeast strains overexpressing U5 and U6 snRNAs and their variants was sequenced to monitor alternative 5’SS selection. Area under the peak was integrated (similar to <xref ref-type="fig" rid="F1">Figure 1</xref>) the find the relative abundance of the two mRNA isoforms.The values on the right of the peaks indicate relative % abundance of respective mRNA isoforms. <bold>(c)</bold> The expression of Heh1 protein isoforms upon overexpression of U5 and U6 snRNA variants monitored by western blots. Data shown as mean ± s.d. (n=3 independent replicates). Orange upward triangle (▴) indicates snRNA overexpression resulting in relatively higher amount of Heh1S protein.</p></caption><graphic xlink:href="EMS206357-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>B complex factors are dispensable for alternative splicing from specific 5’SS variants.</title><p><bold>(a)</bold> Pairing of U5 and U6 snRNAs to <italic>HEH1 WT</italic> pre-mRNA, variant 7 <italic>HEH1S</italic>•{A(+4)U} or <italic>HEH1L</italic>•{A(−1)U}; variant 15 {<italic>HEH1S</italic>•{G(+7)A,A(+8)U,G(+9)A} or <italic>HEH1L</italic>•{G(+3)A,A(+4)U,G(+5)A}; and variant 18 <italic>HEH1S</italic>•{C(+2)U,A(+4)U,G(+7)A,A(+8)U} or <italic>HEH1L</italic>•{C(−3)U,A(−1)U,G(+3)A,A(+4)U}. <bold>(b)</bold> The effect of variants 7, 15, and 18 on <italic>HEH1</italic> alternative splicing was analyzed in different mutant strains by western blot. Data shown as mean ± s.d. (n=3 independent repeats). <bold>(c)</bold> <italic>ACT1</italic>−<italic>CUP1</italic> reporter was used to understand the outcomes in variant 7. U5 and U6 snRNAs pairing to <italic>HEH1S</italic> 5’SS GCAAGU, GCA<underline>U</underline>GU and G<underline>U</underline>A<underline>U</underline>GU were compared by the reporter assay. The 5’SS mutants were analyzed by growth at indicated CuSO<sub>4</sub> concentrations, which correlates with their splicing efficiency.</p></caption><graphic xlink:href="EMS206357-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>5’SS compete for U6 snRNA.</title><p><bold>(a)</bold> Pairing of U6 snRNA with <italic>HEH1 WT</italic> pre-mRNA, variant 10 <italic>HEH1S</italic>•{U(+10)A} or <italic>HEH1L</italic>•{U(+6)A}; variant 15 {<italic>HEH1S</italic>•{G(+7)A,A(+8)U,G(+9)A} or <italic>HEH1L</italic>•{G(+3)A,A(+4)U,G(+5)A}; and variant 20 {<italic>HEH1S</italic>•{G(+7)A,A(+8)U,G(+9)A,U(+10)A} or <italic>HEH1L</italic>•{G(+3)A,A(+4)U,G(+5)A,U(+6)A}. Up/down arrows (↑/↓) indicate increase/decrease in U5 / U6 pairing and competition among the two sites. <bold>(b)</bold> <italic>HEH1</italic>−<italic>CUP1</italic> alternative splicing reporters made by replacing <italic>ACT1</italic> with <italic>HEH1</italic> segment in <italic>ACT1</italic>−<italic>CUP1</italic> reporter. In <italic>HEH1S</italic>−<italic>CUP1, HEH1S</italic> mRNA is in frame with <italic>CUP1</italic>, and in <italic>HEH1L</italic>−<italic>CUP1, HEH1L</italic> mRNA is in frame with <italic>CUP1</italic>. The sequence used was from 1874-2095 for <italic>HEH1S</italic>−<italic>CUP1</italic> and 1874-2094 for <italic>HEH1L</italic>−<italic>CUP1</italic>. <bold>(c)</bold> Reporter activities were tested at different CuSO<sub>4</sub> concentrations (in mM). (◂) The left pointed triangle denotes the abolished <italic>HEH1L</italic> 5’SS in the variant 10 and weak U6 pairing in the variant 20. <bold>(d)</bold> The <italic>HEH1S</italic>−<italic>CUP1</italic> reporter variants were tested for their splicing efficiency by yeast growth at different CuSO<sub>4</sub> concentrations.</p></caption><graphic xlink:href="EMS206357-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>U5 and U6 snRNA variants can bypass the need for B and Bact proteins.</title><p><bold>(a)</bold> The pairing of U5•{U(98)C}, U6•{A(45)U and U6•{A(45)U,U(46)C} to <italic>HEH1</italic> alternative isoforms compared to <italic>WT</italic> snRNA. Up / down arrow means (↑/↓) increase/decrease in U5/U6 pairing compared to <italic>WT</italic> snRNA in <italic>HEH1</italic> isoforms. <bold>(b)</bold> Both U5 and U6 variants were overexpressed in different mutant strains for their effect on <italic>HEH1</italic> alternative splicing. The relative abundance of the protein isoforms was monitored by Western blots. Data shown as mean ± s.d. (n=3 independent repeats). <bold>(c)</bold> The schematics show changes from B to Bact complex for the <italic>HEH1</italic> alternative splicing. Snu66 escorts Hub1 to the spliceosome<sup><xref ref-type="bibr" rid="R28">28</xref></sup> towards the 5’ exon in early B complex, and hands over to the Spp381 (Prp38 complex subunit) <sup><xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R56">56</xref></sup> in the late B complex. Hub1 interacts with the 5’ exon at the exon-intron boundary. Snu66 and Spp381 binding to the Hub1 may be mutually exclusive. Tri-snRNP factors Prp6, Prp3 and Prp31 are present throughout the B complex. They likely stabilise the U4/U6 snRNA duplex and prevent its premature unbinding<sup><xref ref-type="bibr" rid="R63">63</xref></sup>. Prp8 changes from a partially open conformation to a closed state from B to Bact<sup><xref ref-type="bibr" rid="R50">50</xref>,<xref ref-type="bibr" rid="R62">62</xref></sup>. The changes in Prp8 RH domain β-hairpin to loop conformation orchestrate the release of tri-snRNP factors and incorporation of NTC into the spliceosome<sup><xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R62">62</xref></sup>.</p></caption><graphic xlink:href="EMS206357-f006"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Plasmids used in this study.</title></caption><table frame="box" rules="all"><thead><tr><th valign="top" align="left">ID</th><th valign="top" align="left">Name</th><th valign="top" align="left">Plasmids</th><th valign="top" align="left">Description</th><th valign="top" align="left">Ref.</th></tr></thead><tbody><tr><td valign="top" align="left">3658</td><td valign="top" align="left">WT</td><td valign="top" align="left">YC111 pGAL-3MYC−<break/><italic>HEH1-tADH</italic></td><td valign="top" align="left"><italic>S. cerevisiae HEH1</italic> gene under GAL promoter with 3MYC tag at the N- terminus and ADH terminator</td><td valign="top" align="left">Mishra et al. 2011</td></tr><tr><td valign="top" align="left">D1401</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (A1913T)-tADH</td><td valign="top" align="left">A1913T mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1402</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (A1915T)-tADH</td><td valign="top" align="left">A1915T mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1403</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (G1916T)-tADH</td><td valign="top" align="left">G1916T mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1404</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (G1916A)-tADH</td><td valign="top" align="left">G1916A mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1405</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (C1918A)-tADH</td><td valign="top" align="left">C1918A mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1406</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (C1918T)-tADH</td><td valign="top" align="left">C1918T mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1407</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (A1920T)-tADH</td><td valign="top" align="left">A1920T mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1408</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (G1923A)-tADH</td><td valign="top" align="left">G1923A mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1409</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (A1924T)-tADH</td><td valign="top" align="left">A1924T mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1410</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (T1926A)-tADH</td><td valign="top" align="left">T1926A mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1411</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (A1920T, A1924T)- tADH</td><td valign="top" align="left">A1920T, A1924T mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1412</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (G1923C, A1924T)-tADH</td><td valign="top" align="left">G1923C, A1924T mutation pGAL<break/>3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1413</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (C1918T, A1919C,<break/>A1920T)-tADH</td><td valign="top" align="left">C1918T, A1919C, A1920T mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1414</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (A1920T, G1923A,<break/>A1924T)-tADH</td><td valign="top" align="left">A1920T, G1923A, A1924T mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1415</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (G1923A, A1924T,<break/>G1925A)-tADH</td><td valign="top" align="left">G19223A, A1924T, G1925A mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1416</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (G1923A, A1924T, G1925T, T1926A)-tADH</td><td valign="top" align="left">G1923A, A1924T, G1925T, T1926A mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1417</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (G1923A, A1924T,<break/>G1925A, T1926A,<break/>A1927C)-tADH</td><td valign="top" align="left">G1923A, A1924T, G1925A, T1926A, A1927C mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1418</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (C1918T, A1920T, G1923A, A1924T)-tADH</td><td valign="top" align="left">C1918T, A1920T, G1923A, A1924T mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1419</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (G1921A)-tADH</td><td valign="top" align="left">G1921A mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1420</td><td valign="top" align="left"/><td valign="top" align="left">YC111 pGAL-3MYC−heh1 (G2046C)-tADH</td><td valign="top" align="left">G2046C mutation pGAL 3MYC−heh1 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D897</td><td valign="top" align="left"/><td valign="top" align="left">YE112 pADH-3myc−<break/>Snu66-tADH</td><td valign="top" align="left"><italic>S. cerevisiae SNU66</italic> gene under GAL promoter with 3MYC tag at the N-terminus and ADH terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D909</td><td valign="top" align="left"/><td valign="top" align="left">YE112 pADH-3myc−snu66-RRAA-tADH</td><td valign="top" align="left">R16A, R47A mutation pGAL 3MYC−snu66 tADH</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D605</td><td valign="top" align="left"/><td valign="top" align="left">YC333 pHUB1-Hub1- tADH</td><td valign="top" align="left"><italic>S. cerevisiae HUB1</italic> gene under its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1382</td><td valign="top" align="left"/><td valign="top" align="left">YC333 pHUB1-<break/>Hub1(R9A)-tADH</td><td valign="top" align="left">R9A mutation pHUB1-Hub1-tHUB1</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1383</td><td valign="top" align="left"/><td valign="top" align="left">YC333 pHUB1- Hub1(K13A)-tADH</td><td valign="top" align="left">K13A mutation pHUB1-Hub1-tHUB1</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1384</td><td valign="top" align="left"/><td valign="top" align="left">YC333 pHUB1-<break/>Hub1(R9A, K13A)-tADH</td><td valign="top" align="left">R9A, K13A mutation pHUB1-Hub1- tHUB1</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D739</td><td valign="top" align="left"/><td valign="top" align="left">YC333 pHUB1- Hub1(D22A)-tADH</td><td valign="top" align="left">D22A mutation pHUB1-Hub1-tHUB1</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D740</td><td valign="top" align="left"/><td valign="top" align="left">YC333 pHUB1- Hub1(H63L)-tADH</td><td valign="top" align="left">H63L mutation pHUB1-Hub1-tHUB1</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">3743</td><td valign="top" align="left"/><td valign="top" align="left">PRP8+ WT TRP CEN</td><td valign="top" align="left">PRP8 with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1421</td><td valign="top" align="left"><italic>prp8-161</italic></td><td valign="top" align="left">prp8 (P986T) TRP CEN</td><td valign="top" align="left">prp8 (P986T) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1422</td><td valign="top" align="left"><italic>prp8*</italic></td><td valign="top" align="left">prp8 (P1384L) TRP<break/>CEN</td><td valign="top" align="left">prp8 (P1384L) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1423</td><td valign="top" align="left"><italic>syf77</italic></td><td valign="top" align="left">prp8 (L1577F) TRP CEN</td><td valign="top" align="left">prp8 (L1577F) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1424</td><td valign="top" align="left"><italic>prp8-107</italic></td><td valign="top" align="left">prp8 (F1834L) TRP CEN</td><td valign="top" align="left">prp8 (F1834L) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1425</td><td valign="top" align="left"><italic>prp8-cat</italic></td><td valign="top" align="left">prp8 (F1851L) TRP CEN</td><td valign="top" align="left">prp8 (F1851L) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1426</td><td valign="top" align="left"><italic>prp8-cat</italic></td><td valign="top" align="left">prp8 (V1860D) TRP<break/>CEN</td><td valign="top" align="left">prp8 (V1860D) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1427</td><td valign="top" align="left"><italic>prp8-201</italic></td><td valign="top" align="left">prp8 (T1861P) TRP<break/>CEN</td><td valign="top" align="left">prp8 (T1861P) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1428</td><td valign="top" align="left"><italic>prp8-cat</italic></td><td valign="top" align="left">prp8 (V1862D) TRP CEN</td><td valign="top" align="left">prp8 (V1862D) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1429</td><td valign="top" align="left"><italic>prp8-D143</italic></td><td valign="top" align="left">prp8 (K1864E) TRP<break/>CEN</td><td valign="top" align="left">prp8 (K1864E) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1430</td><td valign="top" align="left"/><td valign="top" align="left">prp8 (T1865K)TR P CEN</td><td valign="top" align="left">prp8 (T1865K) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1431</td><td valign="top" align="left"><italic>prp8-162</italic></td><td valign="top" align="left">prp8 (V1870N) TRP<break/>CEN</td><td valign="top" align="left">prp8 (V1870N) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">3745</td><td valign="top" align="left"><italic>prp8-101</italic></td><td valign="top" align="left">prp8 (E1960K) TRP<break/>CEN</td><td valign="top" align="left">prp8 (E1960K) with its own promoter and terminator</td><td valign="top" align="left"/></tr><tr><td valign="top" align="left">D1432</td><td valign="top" align="left"><italic>prp8-153</italic></td><td valign="top" align="left">prp8 (E1982A) TRP<break/>CEN</td><td valign="top" align="left">prp8 (E1982A) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1433</td><td valign="top" align="left"><italic>prp8-161, prp8-101</italic></td><td valign="top" align="left">prp8 (P986T) TRP CEN</td><td valign="top" align="left">prp8 (P986T, E1960K) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1434</td><td valign="top" align="left"><italic>prp8-162</italic></td><td valign="top" align="left">prp8 (V1870N) TRP<break/>CEN</td><td valign="top" align="left">prp8 (F1834L, E1960K) with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1435</td><td valign="top" align="left"/><td valign="top" align="left">YC111 <italic>pGAL-SNU17-</italic> tADH</td><td valign="top" align="left"><italic>S. cerevisiae SNU17</italic> gene under GAL promoter and ADH terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1436</td><td valign="top" align="left"/><td valign="top" align="left">YC111 <italic>pGAL-ECM2-</italic> tADH</td><td valign="top" align="left"><italic>S. cerevisiae ECM2</italic> gene under GAL promoter and ADH terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1437</td><td valign="top" align="left"/><td valign="top" align="left">YC111 <italic>pGAL-URN1-</italic> tADH</td><td valign="top" align="left"><italic>S. cerevisiae URN1</italic> gene under GAL promoter and ADH terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1438</td><td valign="top" align="left">U1•{WT}</td><td valign="top" align="left">pYE195 SNR19-WT +</td><td valign="top" align="left"><italic>S. cerevisiae</italic> SNR19-WT+ gene with its own promoter(1000bp) and terminator(310bp)</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1439</td><td valign="top" align="left">U1•{A7G}</td><td valign="top" align="left">pYE195 snr19 (A7G)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr19 (A7G) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1440</td><td valign="top" align="left">U5•{WT}</td><td valign="top" align="left">pYE195 SNR7-L-WT +</td><td valign="top" align="left"><italic>S. cerevisiae</italic> SNR 7-L-WT+ gene with its own promoter(100bp) and terminator(294bp)</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1441</td><td valign="top" align="left">U5•{U(98)C}</td><td valign="top" align="left">pYE195 snr7-L(U98C)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr7-L (U98C) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1442</td><td valign="top" align="left">U5•{U(98)G}</td><td valign="top" align="left">pYE195 snr7-L(U98G)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr7-L (U98G) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1443</td><td valign="top" align="left">U5•{U(98)A}</td><td valign="top" align="left">pYE195 snr7-L(U98A)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr7-L (U98A) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1444</td><td valign="top" align="left">U6•{WT}</td><td valign="top" align="left">pYE195 SNR6-WT +</td><td valign="top" align="left"><italic>S. cerevisiae</italic> SNR6-WT+ gene with its own promoter(1000bp) and terminator(374bp)</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1445</td><td valign="top" align="left">U6•{A51G}</td><td valign="top" align="left">pYE195 snr6(A51G)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr6 (A51G) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1446</td><td valign="top" align="left">U6•{A51U}</td><td valign="top" align="left">pYE195 snr6(A51U)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr6 (A51U) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1447</td><td valign="top" align="left">U6•{G50U}</td><td valign="top" align="left">pYE195 snr6(G50U)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr6 (G50U) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1448</td><td valign="top" align="left">U6•{G50C}</td><td valign="top" align="left">pYE195snr6(G50C)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr6 (G50C) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1449</td><td valign="top" align="left">U6•{A49U}</td><td valign="top" align="left">pYE195sn r6(A49U)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr6 (A49U) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1450</td><td valign="top" align="left">U6•{U46C}</td><td valign="top" align="left">pYE195snr6(U46O)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr6 (U46C) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1451</td><td valign="top" align="left">U6•{A45U}</td><td valign="top" align="left">pYE195sn r6(A45U)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr6 (A45U) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1452</td><td valign="top" align="left">U6•{A45G}</td><td valign="top" align="left">pYE195snr6(A45G)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr6 (A45G) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">D1453</td><td valign="top" align="left">U6•{T46C, A45T}</td><td valign="top" align="left">pYE195 snr6(T46C, A45T)</td><td valign="top" align="left"><italic>S. cerevisiae</italic> snr6 (T46C, A45T) gene with its own promoter and terminator</td><td valign="top" align="left">This study</td></tr></tbody></table></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Yeast strains used in this study.</title></caption><table frame="box" rules="all"><thead><tr><th valign="top" align="left">Strain</th><th valign="top" align="left">Genotype</th><th valign="top" align="left">Ref.</th></tr></thead><tbody><tr><td valign="top" align="left">YJU75<break/>(SC11)</td><td valign="top" align="left"><italic>MATa ade2 cup1Δ∷ura3 his3 leu2 lys2 prp8Δ∷LYS2 trpl; pJU169 (PRP8 URA3 CEN ARS)</italic></td><td valign="top" align="left">Gift from C.<break/>Guthrie</td></tr><tr><td valign="top" align="left">SC87</td><td valign="top" align="left">YJU75 <italic>hub1∷</italic>KanMX6</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC196</td><td valign="top" align="left">YJU75 PRP8TRP</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC197</td><td valign="top" align="left">YJU75 <italic>prp8-101 TRP</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC198</td><td valign="top" align="left">YJU75 PRP8 TRP <italic>hub1∷</italic>KanMX6</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC200</td><td valign="top" align="left"><italic>YJU75 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC214</td><td valign="top" align="left"><italic>YJU75 prp8-101P<sub>CUP1-1</sub> TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC224</td><td valign="top" align="left"><italic>YJU75 hub1∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC297</td><td valign="top" align="left">SC200 <italic>nam8∷</italic>KanMX6</td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC321</td><td valign="top" align="left">SC11. Dib1−<italic>hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC322</td><td valign="top" align="left">SC11. Prp31−<italic>hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC323</td><td valign="top" align="left">SC11. Sad1−<italic>hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC324</td><td valign="top" align="left">SC87. Dib1−<italic>hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC325</td><td valign="top" align="left">SC87. Prp31−<italic>hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC326</td><td valign="top" align="left">SC87. Sad1−<italic>hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left"><italic>BY4741</italic></td><td valign="top" align="left"><italic>MATa his3A1 leu2A0 met15Δ0 ura3Δ0</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM601</td><td valign="top" align="left"><italic>BY4741 hub1 ∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM602</td><td valign="top" align="left"><italic>BY4741 lea1∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM603</td><td valign="top" align="left"><italic>BY4741 ecm2∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM604</td><td valign="top" align="left"><italic>BY4741 bud13∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM605</td><td valign="top" align="left"><italic>BY4741 nup60∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM606</td><td valign="top" align="left"><italic>BY4741 lsm1∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM607</td><td valign="top" align="left"><italic>BY4741 sky1∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM608</td><td valign="top" align="left"><italic>BY4741 snu17∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM609</td><td valign="top" align="left"><italic>BY4741 pml1∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM610</td><td valign="top" align="left"><italic>BY4741 urn1∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM611</td><td valign="top" align="left"><italic>BY4741 mlp2∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM612</td><td valign="top" align="left"><italic>BY4741 mlp1∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM613</td><td valign="top" align="left"><italic>BY4741 pml39∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM614</td><td valign="top" align="left"><italic>BY4741 brr1∷KanMX6 P<sub>CUP1-1</sub> TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM615</td><td valign="top" align="left"><italic>BY4741 mud2∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM616</td><td valign="top" align="left"><italic>BY4741 mud1∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM617</td><td valign="top" align="left"><italic>BY4741 prp17∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM618</td><td valign="top" align="left"><italic>BY4741 npl3∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM619</td><td valign="top" align="left"><italic>BY4741 cwc15∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM620</td><td valign="top" align="left"><italic>BY4741 cwc21∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM621</td><td valign="top" align="left"><italic>BY4741 cwc27∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM622</td><td valign="top" align="left"><italic>BY4741 ntc20∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM623</td><td valign="top" align="left"><italic>BY4741 ntc30∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM624</td><td valign="top" align="left"><italic>BY4741 ntc31∷KanMX6 P<sub>CUP1-1</sub>TAP−SRC1∷natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left"><italic>W303</italic></td><td valign="top" align="left"><italic>ade2-1 his3-11, 15 leu2-3, 112 ura3 trp1-1 ssd1 can1-100</italic></td><td valign="top" align="left">Gift from K.<break/>Nasmyth</td></tr><tr><td valign="top" align="left">YSKM625</td><td valign="top" align="left"><italic>W303a P<sub>CUP-1</sub>TAP−SRC1∷KanMX6</italic></td><td valign="top" align="left"/></tr><tr><td valign="top" align="left">YSKM626</td><td valign="top" align="left">W303a <italic>P<sub>CUP1-1</sub>TAP−SRC1∷KAN Prp8−hub1(D22A)</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM627</td><td valign="top" align="left">W303a <italic>P<sub>CUP1-1</sub>TAP−SRC1∷KAN Snu66−hub1(D22A)</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM628</td><td valign="top" align="left">W303a <italic>P<sub>CUP1-1</sub>TAP−SRC1∷KAN Prp38−hub1(D22A)</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM629</td><td valign="top" align="left">W303a <italic>P<sub>CUP1-1</sub>TAP−SRC1∷KAN Snu66−hub1(D22A) Prp38−hub1(D22A)</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM630</td><td valign="top" align="left"><italic>W303a hub1∷HIS3MX6 P<sub>CUP1-1</sub>TAP−SRC1∷KanMX6 SNU17−hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM631</td><td valign="top" align="left"><italic>W303a hub1∷HIS3MX6 P<sub>CUP1-1</sub>TAP−SRC1∷KanMX6 PRP4−hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM632</td><td valign="top" align="left"><italic>W303a hub1∷HIS3MX6 P<sub>CUP1-1</sub>TAP−SRC1∷KanMX6 BRR2−hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM633</td><td valign="top" align="left"><italic>W303a hub1∷HIS3MX6 P<sub>CUP1-1</sub>TAP−SRC1∷KanMX6 PRP6−hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM634</td><td valign="top" align="left"><italic>W303a hub1∷HIS3MX6 P<sub>CUP1-1</sub>TAP−SRC1∷KanMX6 PRP3−hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM635</td><td valign="top" align="left"><italic>W303a hub1∷HIS3MX6 P<sub>CUP1-1</sub>TAP−SRC1∷KanMX6 LEA1−hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM636</td><td valign="top" align="left"><italic>W303a hub1∷HIS3MX6 P<sub>CUP1-1</sub>TAP−SRC1∷KanMX6 PRP9−hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM637</td><td valign="top" align="left"><italic>W303a hub1∷HIS3MX6 P<sub>CUP1-1</sub>TAP−SRC1∷KanMX6 PRP11−hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM638</td><td valign="top" align="left"><italic>W303a hub1∷HIS3MX6 P<sub>CUP1-1</sub>TAP−SRC1∷KanMX6 MUD1−hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">YSKM639</td><td valign="top" align="left"><italic>W303a hub1∷HIS3MX6 P<sub>CUP1-1</sub>TAP−SRC1∷KanMX6 NAM8−hub1(D22A)∷ natNT2</italic></td><td valign="top" align="left">This study</td></tr><tr><td valign="top" align="left">SC186</td><td valign="top" align="left"><italic>W303a snu66∷HIS3MX6</italic></td><td valign="top" align="left">This study</td></tr></tbody></table></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Splicing reporters used in this study.</title></caption><table frame="box" rules="all"><thead><tr><th valign="top" align="left">Splicing Reporters</th><th valign="top" align="left">Description</th></tr></thead><tbody><tr><td valign="top" align="left"><italic>ACT1−CUP1</italic> reporter</td><td valign="top" align="left"><list list-type="simple" id="L1"><list-item><label>i)</label><p>5’SS GUAUGU (Gift from C. Guthrie)</p></list-item><list-item><label>ii)</label><p>5’SS GCAUGU (D1454)</p></list-item><list-item><label>iii)</label><p>5’SS GCAAGU (D1455)</p></list-item></list>
</td></tr><tr><td valign="top" align="left"><italic>HEH1L−CUP1</italic> reporter</td><td valign="top" align="left"><italic>ACT1</italic> exon1-intron-exon2 in <italic>ACT1−CUP1</italic> reporter is replaced with <italic>HEH1</italic> exon1-intron-exon2 (nucleotides 1874-2094) to keep <italic>HEH1L</italic> 5’SS GUGAGU in frame with <italic>CUP1.</italic> Its variants were made using SDM.<break/> <list list-type="simple" id="L2"><list-item><label>i)</label><p>5’SS <underline>GUGAGU</underline>AC (D1456)</p></list-item><list-item><label>ii)</label><p>5’SS <underline>GUGAGA</underline>AC (D1457)</p></list-item><list-item><label>iii)</label><p>5’SS <underline>GUAUAU</underline>AC (D1458)</p></list-item><list-item><label>iv)</label><p>5’SS <underline>GUAUAA</underline>AC (D1459)</p></list-item><list-item><label>v)</label><p>5’SS <underline>GUAUGU</underline>AC (D1460)</p></list-item></list>
</td></tr><tr><td valign="top" align="left"><italic>HEH1S−CUP1</italic> reporter</td><td valign="top" align="left"><italic>ACT1</italic> exon1-intron-exon2 in <italic>ACT1−CUP1</italic> reporter is replaced with <italic>HEH1</italic> exon1-intron-exon2 (nucleotide 1874-2095) to keep <italic>HEH1S</italic> 5’SS GCAAGU in frame with <italic>CUP1.</italic> Its variants were made using SDM.<break/> <list list-type="simple" id="L3"><list-item><label>i)</label><p>5’SS <underline>GCAAGU</underline>GUGAGUAC (D1461)</p></list-item><list-item><label>ii)</label><p>5’SS <underline>GCAAGU</underline>GUGAGAAC (D1462)</p></list-item><list-item><label>iii)</label><p>5’SS <underline>GCAACU</underline>GUAUAUAC (D1463)</p></list-item><list-item><label>iv)</label><p>5’SS <underline>GCAAGU</underline>GUAUAAAC (D1464)</p></list-item><list-item><label>v)</label><p>5’SS <underline>GCAAGU</underline>GUAUGUAC (D1465)</p></list-item></list>
</td></tr><tr><td valign="top" align="left"><italic>HEH1L−LACZ</italic><break/>reporter</td><td valign="top" align="left"><italic>RP51</italic> exon1-intron-exon2 is replaced with <italic>HEH1</italic> exon1-intron-exon2<break/>(nucleotide 1792-2190) is fused with the <italic>LACZ</italic> gene to keep <italic>HEH1L</italic> 5’SS<break/>GUGAGU in frame with <italic>LACZ.</italic></td></tr><tr><td valign="top" align="left"><italic>HEH1S−LACZ</italic><break/>reporter</td><td valign="top" align="left"><italic>RP51</italic> exon1-intron-exon2 is replaced with <italic>HEH1</italic> exon1-intron-exon2<break/>(nucleotide 1792-2191) is fused with the <italic>LACZ</italic> gene to keep <italic>HEH1S</italic> 5’SS<break/>GCAAGU in frame with <italic>LACZ.</italic></td></tr></tbody></table></table-wrap></floats-group></article>